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Many  complex  diseases  are  known  to  have  a  substantial  genetically  heritable 
component.  Elucidation  of  these  genetic  risk  factors  provides  increased 
knowledge of  the biological mechanisms  that  result  in  the diseases while  also 
presenting  new  potential  targets  for  therapy.  This  thesis  explores  the 









deal  with  medication,  methods  to  determine  kinship  between  individuals, 
linkage analysis, association analysis and meta‐analysis of multiple studies. 
 










Chapter  5  introduces  additional  traits  derived  by  pulse  wave  analysis  and 
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1 Chapter 1: Introduction to genetic mapping in complex 
disease 
Wars, violence, accidents and suicide account for less than 10% of worldwide deaths 
each year. The remaining 90% of deaths are the result of some form of disease(WHO 
2008). These diseases can be broadly divided into two categories: Those that are 
communicable and those that are not. 
 
In developing regions the communicable diseases represent by far the largest health 
burden with, for example; according to the world health organization (WHO) 2004 
report(WHO 2008), 68% of all deaths in Africa attributed to communicable disease 
and only 25% resulting from non-communicable conditions. 
 
In regions with the most developed infrastructure the communicable group of 
diseases account for a considerably smaller proportion of annual deaths. In Europe 
only 6% of deaths are attributed to communicable disease and 86% to non-
communicable disease. 
 
Logically, regions with low rates of infectious disease deaths will have a higher 
proportion and total number of non-communicable disease deaths since, ultimately, 
everyone has to die of something. However, the higher proportion of non-
communicable disease deaths in the developed world also represents a genuine 
increase in the burden caused by certain diseases compared to less developed 
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countries. Looking specifically at men aged 45-59; the CVD mortality rate among 
Africans is estimated to be 38 per 10,000, compared to 44 per 10,000 among 
European men; illustrating an increased rate of heart disease in relatively young men 
in the developed world.  
 
From the perspective of a geneticist; even in a hypothetical controlled environment 
free of infectious agents or damaging environmental exposures there would still be 
variation in the diseases people die from and in the age at which they develop them. 
This is because the many common non-communicable diseases have a genetically 
heritable component and heritability estimates for categories such as “major 
psychoses, early-onset ischaemic heart disease, rheumatoid arthritis, ankylosing 
spondylitis and diabetes mellitus” were reported more than 40 years ago (Carter 
1969). Identification of the heritable component of complex diseases is the main 
topic of this thesis. 
 
The heritability of a disease or phenotype is an estimate of that proportion of the 
phenotypic variation that is due to inherited genetic factors and is sometimes used as 
a rationale for describing the importance of studying the potential genetic effects of a 
particular disease. It is also used retrospectively as a guide to how successful studies 
have been in identifying meaningful information about the role of genetic 
factors(Maher 2008). Heritability estimates can be calculated as either narrow sense 
estimates, which represent the proportion of variance attributable to additive genetic 
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effects, or broad sense heritability, which includes both additive effects and 
dominance effects. 
 
It is important to interpret the heritability estimate in the correct context. Firstly 
bearing in mind that the estimate is a proportion of total variance and is therefore 
inversely proportional to other forms of phenotypic variance. This means that 
differences in levels of environmental variation will result in different heritability 
estimates for the same phenotype and so an estimate is only truly representative of 
the population in which it was calculated.  
 
Heritability estimates are also sensitive to measurement error as this will both 
increase the total phenotypic variance and confound the observed covariance 
between genotype and phenotype(Macgregor, Cornes et al. 2006). This can result in 
phenotypes with relatively poor repeatability such as blood pressure or spirometric 
measures appearing to have less significant genetic components than more easily 
measureable traits but does not mean that there are not significant genetic 
components affecting the phenotype.  
 
There are 6 currently known major types of genetic variation that can account for the 
heritable variation in a phenotype or disease. Firstly and perhaps most obviously are 
changes in the coding sequence of a gene and the resultant alterations of its product. 
A single base substitution can occur at any point in the genome and does so in each 
generation. The rate at which these mutations occur in the human germ-line has been 
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estimated in a variety of ways as far back as 1935 (Haldane 2004) but the most 
recent estimates suggest an autosomal base substitution rate of approximately 
1.3x10-8 per site per generation corresponding to roughly 50-100 novel mutations in 
each individual (Lynch 2010). While germline mutations can result in phenotypic 
variation they will not initially contribute to the estimated heritability of a phenotype 
since they are only present in a single individual. They are however the ancestral 
source of the polymorphic sites which result in heritable genetic variance in many 
complex diseases. 
 
The vast majority of these polymorphic loci will occur in regions of non-transcribed 
DNA since these regions make up roughly 98% of the human genome(Elgar and 
Vavouri 2008). However, a small proportion of polymorphisms occur within the 
transcribed sequence of genes.  
 
The impact of polymorphisms within transcribed sequence is site specific and highly 
variable. Firstly the structure of amino acid codons, with 3 bases each of which can 
be one of 4 nucleotides, results in a great deal of redundancy with 64 alternative 
codons translating into only 20 different amino acids and 1 stop signal. Each codon 
is made up of 3 bases each of which can be mutated to one of 3 alternative bases so a 
single base substitution results in a change to 1 of 9 alternate codons. If there were an 
even distribution and random assignment of codons across amino acids this 
redundancy would give an average of 3.05 codons per amino acid and the probability 
of this resulting in an amino acid substitution or creation of a premature stop codon 
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would be 1-(3.05/64), approximately 95.2%. However, the relationship between 
codons and amino acids is not random or evenly distributed.    
 
The actual number of codons per amino acid ranges between 1 and 6 with a median 
of 2 and groups of codons that code for a particular amino acid generally share a 
similar structure with the first base being most strongly conserved and in many cases 
the third base being completely interchangeable.  
 
This structured coding results in different probabilities of non-synonymous changes 
for different amino acids. Tryptophan and methionine, which shares its genetic code 
with the transcriptional start site, have unique codons and so are susceptible to any 
base substitution. Conversely, arginine, serine and leucine each have 6 alternate 
codons and so the probability of a synonymous base substitution is highest in the 
codons for these residues. 
 
Besides altering the protein coding sequence of a gene a single base substitution can 
also disrupt splice sites that will result in alteration of the splicing pattern of exons in 
the messenger RNA. This will result in entire sections of the protein product being 
absent rather than an alteration of a single residue. 
 
Similarly to splice site disruptions, single base insertions or deletions within coding 
sequence can also have a large impact on the protein product produced. This causes a 
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frame shift of the entire coding sequence downstream of the mutation and results in 
the majority of the amino acid residues being miscoded. 
 
All of the types of coding variation described can be exemplified with reference to 
the recessive monogenic disorder cystic fibrosis (CF). CF is caused by defects in the 
production or function of the cystic fibrosis trans-membrane conductance regulator, 
the gene encoding this protein, CFTR, is known to have over 1,000 functional 
variants with varying frequencies across populations (Rodrigues, Gabetta et al. 
2008).  
 
The most commonly observed disease-causing variant is ΔF508 (Kerem, Rommens 
et al. 1989), A 3 base deletion straddling the 507th and 508th codons of the CFTR 
sequence. Codon 507 changes from ATC to ATT both of which code for isoleucine, 
codon 508 is effectively missing resulting in the loss of a phenylalanine residue. As 
the deletion removes 3 bases it does not change the reading frame of the gene and so 
the remaining coding sequence is transcribed and translated as normal. The loss of 
the phenylalanine residue disrupts the normal folding of the protein produced 
resulting in its degradation before reaching the surface of the cell (Rowe, Miller et al. 
2005). 
 
Another considerably more rare variant in CFTR within the 533rd codon consists of a 
single base C->T substitution, which results in a premature stop codon replacing the 
wild-type Arginine. This causes a truncated non-functional protein to be produced.  
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Yet another single base substitution demonstrates the potential effect of splice site 
variation. A G->C transversion at the 3rd position of the 1291st codon in the 20th exon 
of CFTR results in a Histidine residue in place of the more common Glutamine 
residue. While this does represent a protein coding change it also results in disruption 
of a splice site (Jones, McIntosh et al. 1992). The disruption results in an additional 
29 bases of intronic sequence being included in the mRNA product, and this 
additional sequence contains an in-frame stop codon, which causes premature 
termination of transcription. 
 
The second broad category is changes that affect regulatory elements and modify the 
expression of one or more genes. Promoter regions are usually located near to and 
upstream of the gene they are associated with making them relatively easy to 
identify. Enhancing elements on the other hand can be located a great distance from 
the gene or genes they control. Disruption of either of these types of elements can 
lead to a change in the expression levels of a particular gene so that although the 
gene product is the same it may be present in too large or too small a quantity to 
perform its required role. The expression patterns of certain genes during 
development can be highly specific and so mutations that disrupt the expression 
control can cause strong phenotypic effects. 
 
A third source of genetic variation comes from the fact that individual genes do not 
act alone but rather fall into networks and pathways. This leads to the concept of 
epistasis whereby variation in one gene’s function or expression levels can enhance 
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or negate the effect of variation in another gene. An example of this phenomenon is 
the Bombay phenotype (Hakim, Vyas et al. 1961). This is a rare recessive condition 
in which an individual produces no H-antigen, which is the precursor of A and B 
blood group antigens. Since the person can produce no blood-group antigens they 
appear to be blood group O even if they inherited A or B alleles from their parents.  
 
The fourth source of heritability comes from the interaction of genetic variants and 
environmental variation. In this case the potential phenotypic variation caused by a 
genetic polymorphism may only be observable in certain environmental conditions. 
For example several risk loci for alcohol dependence have been identified and 
confirmed in the last 5 years but it is clear that the effect of these genes will only be 
observable in an environment where alcohol is available and the effects may be 
modified by the attitude towards drinking alcohol prevalent within a given society.  
 
The fifth category of genetic variation, which may contribute to the heritability of 
phenotypic variation, is Copy Number Variants (CNVs). A CNV is essentially 
classified as a region of the genome, which may contain one or more genes, being 
present in variable numbers within a population. Generally each individual has 2 
copies of any section of autosomal DNA but faults can occur during replication 
resulting in the deletion or duplication of a particular region leading to a variable 
dosage effect of the genes present in this region. 
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The sixth and least well-characterized source of variation is heritable methylation. 
Methylation of regions of the genome prevents the binding of transcription factors 
and polymerases thus preventing expression of the genes. Although this does not 
result in any permanent change of the DNA sequence there is evidence to suggest 
that some types of epigenetic modification are passed on from parents to offspring 
and that this could therefore contribute to their phenotypic correlation. 
 
Certain epigenetic changes relate to the imprinting of specific loci during germ-cell 
development and result in differential expression levels of alleles based on whether 
they were maternally or paternally inherited. Many of these imprinted loci have been 
identified both in animal models and in the human genome (Hirasawa and Feil 2010) 
and appropriately designed studies have already begun to identify potential 
phenotypic consequences of this imprinting (Kong, Steinthorsdottir et al. 2009). 
Even though this type of imprinting is reset between generations it has implications 
for the study of genetics by obfuscating the relationship between genotype and 
phenotype at these loci. 
 
In addition to single generation sex-specific imprinting there is also evidence for 
histone modifications and methylation patterns at some loci that can be passed on 
unchanged from one generation to the next (Hammoud, Nix et al. 2009). This 
represents an additional source of heritable variation, with impacts on phenotypic 
variance, which is not yet detectable in DNA sequence analysis.  
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It has also been demonstrated in animal models that patterns of epigenetic variation 
can be inherited through the germ-line through the transmission of small RNA 
molecules. This type of inheritance has been demonstrated to be experimentally 
possible through the introduction of small RNA molecules in mice gametes that 
cause persistent alterations in coat colour (Rassoulzadegan, Grandjean et al. 2006) or 
in cardiac development (Wagner, Wagner et al. 2008) and the presence of RNA 
molecules in unmodified mammalian gametes means that this is an entirely plausible 
hypothesis for trans-generational epigenetic inheritance (Krawetz 2005). 
 
Having established that many diseases have a heritable genetic component the 
challenge becomes identifying more specifically which genes or genomic elements 
are involved in the development of the disease. The characterization of polymorphic 
genetic markers was crucial to this endeavor. The first markers to be used in genetic 
mapping studies were multi-allelic micro-satellite markers, which consist of variable 
repeats of the same short DNA sequence. Repeat sequences such as these have a 
relatively high probability of mutation between generations through slippage during 
replication. This leads to many separate alleles being present within a population 
giving high levels of heterozygosity and allowing the tracking of segments of DNA 
between parents and offspring. 
 
Micro-satellites have been used primarily in linkage mapping for diseases and 
quantitative traits. This technique requires a population of related individuals who 
are measured for the trait in question. Using a genome-wide collection of micro-
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satellite markers and the known relationships between individuals it is possible to 
draw up a map of shared genomic regions. At each point along the linkage map a 
probability that two individuals share the same genotype can be calculated and this 
can then be compared with incidence of the disease or with covariance of a 
quantitative trait. This highlights regions that are likely or unlikely to contain a locus 
with an impact on the phenotype. 
 
Figure 1 demonstrates the simplest possible case of linkage analysis. Individual 1 is a 
female with a genetically heritable disease. She mates with an unaffected male “2” 
producing two daughters “3” and “4” each of which exhibits the same disease. The 
daughters then have children with unaffected men, both represented by individual 
“5”. These unions produce a total of four children “6” who shows no signs of disease 
and “7”, “8” and “9” all of whom have the disease. If we are able to genotype all 
three generations of the family then we can track the inheritance of sections of 
individual “1”s chromosomes through the family and see which sections are shared 
between the affected individuals. In this case the only section shared between “1”, 
“3”, “4”, “7”, “8” and “9” is a short region coloured in red and circled in the last 
generation. This pedigree would suggest the genetic variant underlying the disease is 
located in this region. Separate analysis of other families in which this disease is 
found may give evidence in support or contradiction of this region and a large study 
of several affected families would be needed to confidently identify a linked region. 
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Linkage mapping has proven successful in animal research since the artificial 
selection process imposed on livestock, using a small number of males to sire 
millions of offspring, greatly reduces the effective population size and as a result 
reduces the total genetic heterogeneity with many polymorphic sites rapidly 
becoming fixed in the population. The ability to design specific breeding 
experiments also maximizes the power for this type of analysis.  
 
The linkage mapping technique was also used with success to identify the loci 
responsible for some rare monogenic diseases including the first genetically defined 
for of maturity onset diabetes of the young (MODY)(Bell, Xiang et al. 1991) and a 
form of familial hypercholesterolemia (Eden, Naoumova et al. 2001). When applied 
to the study of complex polygenic diseases and traits linkage has been considerably 
less successful. The strength of linkage analysis lies in identifying loci where rare 
alleles account for a large proportion of phenotypic variance. However, linkage 
mapping has very low power to identify common variants that individually have only 
a small impact on the phenotype. 
 
Association analysis works on a different principle to linkage analysis. Over the 
course of one generation large segments of a chromosome may be passed on intact 
from parent to offspring however over successive generations recombination will 
reduce the size of the section of DNA which is identical to the original ancestral 
segment of DNA. Over dozens of generations the regions of shared DNA are broken 
down to small blocks of a few hundred kilobases, which are still identical to the 
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original DNA. Loci within these sections of DNA are described as being in linkage 
disequilibrium (LD) within a population meaning that the genotypes at these loci are 
correlated with one another. The level of LD between two loci can be calculated by 
examining how often the same alleles at the two loci occur together. If there is high 
LD between two loci then genotyping one can be used to predict the genotype at the 
other and if LD is complete then the section of DNA in between the two loci can be 
assumed to be identical as well. 
 
This process can be used to identify regions of DNA that are expected to be shared 
identical-by-decent (IBD) between two individuals who are apparently unrelated but 
who ultimately share a distant common ancestor. 
 
Association studies generally use bi-allelic Single Nucleotide Polymorphisms (SNPs) 
rather than variable length micro-satellite markers since SNPs are far more 
numerous, have a simpler mutation process, and are much less prone to further 
mutation. As previously mentioned the rate of single base substitution is 
approximately 1.3x10-8 whereas the mutation rate for microsatellites is estimated to 
be between 10-6 and 10-2 (Eckert and Hile 2009).  
 
Initial association studies used markers in and around genes for which there was 
some hypothesis for involvement in a particular disease. These candidate gene 
studies produced some positive results for example demonstrating the link between 
obesity and the melanocortin receptors 4 and 5 (Chagnon, Chen et al. 1997). 
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However, the overall results produced by these types of studies were less dramatic 
than many had hoped.  
 
The two major flaws with candidate gene studies were firstly; the underestimation of 
how many loci would contribute to most complex phenotypes, and therefore the 
overestimation of expected effect size per locus, and secondly; the assumption that 
our prior knowledge of functional genetics would prove a strong enough guide to 
identifying appropriate candidates. 
 
Genome-Wide Association studies (GWAS) attempt to overcome these two flaws. 
The issue of effect size is ameliorated to a certain extent because the heavy burden of 
multiple testing in a GWAS already requires larger sample sizes to distinguish 
between true results and false positives. The GWAS approach also addresses the 
issue of the usefulness of prior functional knowledge by attempting to test all regions 
of the genome. In practice the coverage achieved depends on the density of markers 
used and certain high recombination regions are difficult to tag using LD.  
 
1.1 Relating quantitative traits to disease outcomes 
1.1.1 Study of genetic components of common diseases 
Classical epidemiology involves the discovery and investigation of risk factors 
involved in diseases. This type of research has determined the negative impact which 
modifiable risk factors such as smoking, obesity and stress have on people’s health 
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through the development of complex diseases like Coronary Heart Disease (CHD), 
various forms of cancer and Type 2 Diabetes (T2D). Public health research is in turn 
involved in attempts to reduce the prevalence of these risk factors in the general 
population. Interventions which reduce the amount of smokers or which encourage 
exercise can be expected to improve the general health of the population in the long 
term. 
 
This method is however limited to modifiable risk factors. Most common complex 
disorders are known to have a sizeable genetic component meaning that one 
individual may be born with a higher genetic predisposition to a particular condition 
than another. The study of the genetics of these diseases is therefore important for 
the purposes of understanding more fully the biological pathways that lead to 
disease. This knowledge can be used in turn to guide the development of new 
pharmacological treatments for the disorder.  
 
Historically many drug treatments have been discovered by accident or trial and error 
and are prescribed in standard doses to all patients with a certain set of symptoms. 
Detailed understanding of the underlying biology of diseases allows new products to 
be purposefully designed to produce a specific biological effect. Genetic knowledge 
also allow for differential diagnosis of patients who may be presenting with the same 
set of symptoms but with different underlying causes 
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1.1.2 Study of disease outcomes as binary variables 
GWAS analysis has been used on a variety of common complex diseases using a 
case-control design. The major benefit of this type of study is that large cohorts of 
cases already exist for many conditions and, pending ethical approval, can be used 
along with a suitable set of controls. It is also possible to create and genotype a set of 
control samples that can be re-used for many different diseases thus reducing the 
overall cost of genotyping as was the case with the Wellcome trust case control 
consortium (WTCCC 2007). 
 
The case control design does have certain drawbacks for use in GWAS analysis. 
Firstly the ascertainment of appropriate controls can be difficult depending on the 
disease in question. With late onset conditions a healthy control may in fact be a case 
that has yet to present symptoms.  
 
One strategy to overcome this is to simply use a very large set of un-phenotyped 
controls in which case the increased power from sample size can compensate for the 
effect of cryptic cases being present in the control sample. The benefit of using this 
strategy depends directly on the population prevalence of the study disease since this 
is the proportion of cryptic cases you expect to be present in your un-typed controls. 
It may therefore be highly successful for relatively rare conditions such as type I 
diabetes but will be less effective for very common conditions such as obesity or 
hypertension where some level of control phenotyping may be necessary.  
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A second drawback of the case control design is disease heterogeneity. Disease 
definitions are largely compiled from a set of symptoms. This is clearly useful when 
determining an appropriate course of treatment to address those symptoms but from a 
developmental perspective the same disease outcome may arise from entirely 
separate mechanisms with separate underlying genetic influences. 
 
In the case of Myocardial Infarction (MI) for example, prolonged periods of high 
blood pressure can result in arteriosclerosis increasing the probability of an MI event. 
At the same time, increased blood lipid levels can result in the formation of 
atheromatous plaques, and increase the probability of MI, in individuals with normal 
blood pressure. It is therefore possible that a case control GWAS for MI could be 
testing for association with either blood pressure or blood lipid levels but not doing 
either in an efficient way. 
 
The metabolic syndrome is another example of a disorder diagnosed using a variety 
of component phenotypes. Several different definitions of the syndrome have been 
published since 1988. The definition used by the World Health Organization (WHO) 
requires 3 or more of the following factors: fasting glucose (FG) ≥ 6.05 mmol/l, 
triglycerides ≥ 1.65 mmol/l, high density lipoprotein (HDL) < 1.04/1.29mmol/l for 
men/women respectively, blood pressure ≥ 130/85 mmHg and central obesity 
measured by Waist to Hip Ratio (WHR) or Body Mass Index (BMI). A case control 
GWAS of metabolic syndrome will in reality be testing for all of these phenotypes 
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but none of them are individually sufficient for diagnosis and combinations of the 
components are likely to differ between populations.  
 
An alternative study design involves using continuous quantitative phenotypes 
instead of discreet disease categories. This technique is potentially more powerful 
than, and certainly complementary to, the case control study design in a variety of 
ways. 
 
Firstly, the component phenotypes that underlie a disease are inherently less complex 
than the disease since any variation affecting the phenotype will also result in 
variation in disease risk. This reduction in the number of sources of variation makes 
identification of those sources - in this case genetic polymorphisms - easier. 
 
Secondly the continuous phenotype may have a great deal of variation within the 
disease and healthy categories and this variation may have predictive value for future 
disease. For example, fasting glucose levels are both a diagnostic measure for T2D 
and, at non-pathogenic levels, are a strong predictor of future T2D risk.  
 
In more general terms studying continuous phenotypes has economic advantages 
since each person has a value for any given phenotype and so the same set of people 
can be measured for a large number of different phenotypes. This results in a single 
set of genotyping contributing to studies of a cornucopia of different diseases and 
disorders. 




For these reasons studying the continuous phenotypes that contribute to disease 
development can be a complementary approach to case control analysis. 
 
1.2 Benefits of isolated populations 
Isolated populations are small populations in which geographical or social factors 
have caused a period of genetic isolation, with little or no immigration from other 
populations. The use of isolated populations in the study of human genetics first 
became popular with respect to rare Mendelian recessive disorders. The small 
population sizes result in a background level of inbreeding which increases the 
probability of a rare allele being found in a homozygous state(McQuillan, 
Leutenegger et al. 2008). This is beneficial for genetic mapping strategies both in 
increasing the effect size of additive loci found in a homozygous state and in 
increasing the ability to detect dominant effects. 
 
 Historical population bottlenecks result in longer regions of linkage disequilibrium 
between the disease gene and surrounding markers(Latini, Sole et al. 2004). This is 
also beneficial for genome-wide association mapping techniques as they rely on 
tagging unknown causative variants with a panel of markers. The coverage achieved 
with a given marker panel will be larger in populations with larger LD blocks than in 
populations with small LD blocks(Peltonen, Palotie et al. 2000; Heutink and Oostra 
2002). 
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In terms of linkage analysis isolated populations are also beneficial because they lend 
themselves to the collection of large family groups as participants encourage their 
relatives to join. In this way a significant proportion of the total population can be 
recruited and large family pedigrees can be constructed for use in linkage mapping. It 
has been shown that for variance component linkage analysis of quantitative traits 
extended pedigree study designs achieve greater power to detect quantitative trait 
loci (QTLs) than sib-pair studies with the same total sample size (Williams and 
Blangero 1999). 
 
A theoretical benefit of using a small isolated population in the study of multi-
factorial diseases and traits is that the environmental variance present should be 
lower than when sampling from a large metropolitan or national population(Heutink 
and Oostra 2002). This reduction in the environmental variance should result in an 
increase in the relative proportion of phenotypic variance that results from genetic 
variation. 
 
The small population size and historical bottlenecks also increase the effects of 
selection pressures and random drift both of which can drive polymorphic sites to 
fixation(Pardo, MacKay et al. 2005). In the case of studying a trait that may be 
influenced by tens or hundreds of genes this should result in the fixation of some of 
these genes in a non-polymorphic state. This would then increase the relative 
contribution of the genes that are still variable i.e. giving them large effect sizes and 
making them easier to identify. 




1.3 Statement of aims 
 
The main aims of this thesis are two-fold. Firstly, to investigate methods appropriate 
for the analysis of high-density genetic data in isolated populations. Methods for 
conducting linkage analysis in extended pedigrees are well established(Almasy and 
Blangero 1998; Abecasis, Cherny et al. 2002). However, with the advent of high 
density SNP data, efficient methods for conducting large-scale association studies in 
pedigree data are relatively new (Aulchenko, de Koning et al. 2007; Chen and 
Abecasis 2007). 
 
The second linked aim of this thesis is to identify genetic loci influencing medically 
relevant phenotypes within our isolated population studies, thus providing a proof of 
principle for the methods used. 
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2 Chapter 2: Methods 
2.1 Methods to determine kinship 
An important aspect of both linkage and association analysis studies using related 
individuals is the ascertainment of a kinship matrix defining the relationship between 
each pair of individuals in the study. 
 
Traditionally kinship matrices have been estimated based on known pedigree 
information giving an approximation of the expected level of genetic identity 
between two individuals based on the number and type of links between them in the 
pedigree. A simple example of pedigree-based kinship is the case of full siblings 
with no parental relatedness; At any given point in the genome these siblings have a 
probability of inheriting the same alleles from both parents of 0.25. The probability 
of both siblings inheriting only one identical allele is 0.5 with the remaining 
probability that they each inherit different alleles from both parents, and are therefore 
genetically unrelated at this position, is 0.25. The pedigree based kinship estimate 
will therefore be 0.5 in full sibs with no background inbreeding. 
 
Pedigree based methods have two major sources of inaccuracy. The first is the semi 
random nature of chromosomal recombination means that the theoretical range of 
average allele sharing for full sibs is between 0 and 1. In practice the observed range 
is considerably smaller than this but still introduces an element of stochastic 
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variation that makes pedigree based kinship estimates unrepresentative of the true 
genetic relationship between samples. 
The second source of error in pedigree based kinship estimates is the lack of 
complete information. Within an artificial animal-breeding framework it may be 
possible to keep accurate pedigree information over hundred or thousands of 
generations. In human populations however it may not be possible to trace pedigree 
relationships more than a few generations due to the long generation interval and a 
lack of historical records. The founders of populations must therefore be assumed to 
be unrelated which, particularly in a population isolate, is unlikely to be true. Even 
where large amounts of pedigree data can be collected the accuracy of the 
information cannot be guaranteed as it relies on complete reporting of all births and 
on true paternity always being given which is not always the case. 
 
With the availability of large amounts of genotypic data the relationships between 
individuals can be estimated more accurately than using pedigree information alone 
both in the sense of identifying non-paternity through conflicting genotypes and in 
the sense of gaining a more accurate estimate of the proportion of the genome that a 
pair of related individuals share. 
 
2.2 MERLIN (multipoint engine for rapid likelihood inference) 
The first of the methods used in this project, which utilized pedigree based 
information, was the calculation of multipoint Identity-By-descent (mIBD) matrices 
for use in the linkage analysis.  
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The MERLIN program (Abecasis, Cherny et al. 2002) was designed to extend mIBD 
calculation methods to dense marker sets that could not computationally be handled 
by previous methods. Calculation of mIBD requires a set of genotypes and pedigree 
information. Any two individuals can have 0,1 or 2 alleles at a particular locus that 
appear to be identical by state, IBD estimation attempts to determine the likelihood 
they are also shared identical by decent through some pedigree pathway that 
connects both individuals to a recent common ancestor. 
 
For a single marker IBD estimate within a given pedigree the program requires 3 
things. Firstly an accurate pedigree going back to a set of unrelated founders. 
Secondly the genotype data for the individuals whose IBD must be estimated and 
thirdly an estimate of the founder allele frequencies for that marker. 
 
MERLIN can then calculate all possible sets of founder genotypes and all possible 
patterns of gene flow through the pedigree that would result in the observed 
genotypes. In a complex pedigree there will be multiple scenarios through which the 
observed genotypes could have arisen some of which demonstrate IBD between 
individuals and some that are IBS. The combined likelihoods of scenarios leading to 
IBD can then be calculated. 
 
Multipoint methods are used to calculate the likelihood that two individuals within a 
pedigree are IBD at arbitrarily chosen intervals along the genetic map. This can be 
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done by extension of the single point IBD calculation to include information from 
multiple flanking markers and the recombination distances between them. 
 
2.3  SOLAR (Sequential oligogenic linkage analysis routines) 
The linkage analysis for this project was carried out using the SOLAR package 
(Almasy and Blangero 1998). The program carries out a variance component 
analysis to test for evidence that the phenotypic covariance between individuals is 
caused by their shared genotype at a given genomic location. This analysis was 
carried out at regular intervals across the genome using the mIBD matrices 
previously calculated using MERLIN. 
 
2.4 Association Analysis 
2.4.1 Correcting for population structure 
When carrying out a GWAS analysis we expect, and hope for, some deviation of the 
observed test statistics from the null distribution. The deviation we are hoping to find 
is a result of some proportion of the SNPs tested being non-randomly associated with 
the phenotype being tested. There are however several other sources of inflation.  
 
As our samples are taken from isolated populations we expect the greatest source of 
inflation to arise from increased allele sharing between related individuals and 
familial covariance in phenotypic values.  
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Inflation can also results from population stratification whereby two or more 
genetically divergent populations are treated as a single population. If there are 
differences in both the allele frequencies and phenotypic distributions of the 
unobserved sub-populations then false associations will be produced. 
 
A third source of inflation is genotyping error arising from poorly performing 
genotype assays or errors in the genotype calling algorithm. This can be particularly 
problematic in case-control study designs when the two sample groups are genotyped 
separately. In population based studies such as ours the problem is less pronounced 
as any error should be randomly distributed with respect to the phenotypes being 
tested. 
 
We can control effectively for the population stratification by conducting individual 
analysis of each study population we have available and combining the evidence for 
association using meta-analysis. The issue of family structure is more complex and 
we have tested a variety of methods to account for this. 
 
2.4.2 Genomic Control 
The simplest and fastest method to correct for inflated association statistics in related 
samples is Genomic Control (Devlin and Roeder 1999).  This method is applied after 
association analysis has been performed and attempts to assess and correct for the 
overall inflation of test statistics after said inflation has occurred. 
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Initially the association analysis is performed assuming individuals are unrelated. 
The association of each SNP with a continuous and normally distributed phenotype 
is tested by linear regression, along with appropriate covariates and fixed effects.  
 
We then make the assumption that, even for a highly polygenic phenotype, the vast 
majority of genome-wide markers should not show association and should therefore 
follow the null distribution. So we take the observed distribution of test statistics, in 
this case chi-square values with 1 degree of freedom, and find the median value. 
Subtracting the expected median test statistic gives an estimate of the average level 
of inflation in our analysis (λ). We can then divide the observed test statistic for all 
SNPs by λ to obtained the genomically controlled test statistic. The inflation can be 
visualised with a Quantile-Quantile (QQ) plot in which the observed p-values are 
plotted against the values expected under the null distribution. Figure 2 shows an 
example of the uncorrected p-value distribution for height in the ORCADES study, 
which gives a λ value of 1.44.  Figure 3 shows the distribution after correction for 
this inflation factor. The main body of results now follows the expected null 
distribution but some degree of inflation is still seen in the tail of the results 
indicating higher than expected test statistics for a small proportion of SNPs as 
would be expected if true associated loci are present. 
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Figure 2. QQ-plot of GWAS results for height in the ORCADES population. 
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Figure 3. QQ-plot of GWAS results for height in the ORCADES population after correction for 
inflation by GC (λ   =1.44). 
 
 
The genomic control (GC) method works efficiently when λ is small (Marchini, 
Cardon et al. 2004), for example when inflation is caused by the background cryptic 
relatedness that will be present in any population or by some small degree of 
population admixture. When λ is large, for example due to close family structure 
within the study, genomic control becomes less anti-conservative and fails to fully 
correct for inflation (Devlin, Bacanu et al. 2004). Given appropriate pedigree data, 
alternative methods can be used to more accurately correct for family or population 
structure prior to association analysis.  






One of the methods to adjust for relatedness I examined was Genome-wide Rapid 
Association Using Mixed Model And Regression (GRAMMAR) (Aulchenko, de 
Koning et al. 2007). GRAMMAR is a multistage method using pedigree information 
to adjust the phenotype prior to running GWAS. 
 
The first step is to calculate and correct for the proportion of phenotypic covariance 
that is due to shared kinship, which in this case was done using the ASReml 
software. The program uses the inverse of the relationship matrix rather than the 
relationship matrix both because the inverse matrix is sparser and therefore requires 
less memory to calculate, and because the ultimate aim of the analysis is to remove 
the effect of the relationship matrix by multiplying out the inverse relationship 
matrix.  
 
A mixed model can be used to estimate the effects of covariates (i.e. age), fixed 
effects (i.e. sex) and random effects (i.e. additive polygenic effects and unidentified 
residual effects). The mixed model takes the form: 
 
 
Where γi is the phenotype of the ith individual, µ is the mean phenotypic value,  βj is 
the estimated effect of the jth covariate or fixed effect, Cji is the value of the jth 
€ 
γ i = µ + β jC ji +Gi +ϖ i
j
∑
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covariate or fixed effect for the ith individual. Gi is the additive polygenic effect and 
ϖi is the residual random effect that we wish to calculate.  
 




Gi is defined as the kinship, or relationship, matrix multiplied by the additive 
polygenic variance or estimated narrow-sense heritability of the phenotype.  
 
These residual random effect values can then be used in place of the original 
phenotypic value in a linear regression against SNP genotype and other appropriate 
covariates and fixed effects: 
€ 
ϖ i = µ + kgi + ei  
Where gi is a vector of genotypes at a given SNP k is the effect of that SNP and ei is 
the remaining residual error. 
 
The GRAMMAR method should perform better than GC when heritability estimates 
are substantial and a large degree of inflation is expected. It does however rely on the 
accuracy and completeness of pedigree information. 
 
€ 
ϖ i = γ i − (µ + β jC ji +Gi
j
∑ )




The third and final analysis method used to adjust for relatedness within the sample 
was based on the Family Based Score test for Association (FASTA) (Chen and 
Abecasis 2007). The method is similar to GRAMMAR in the sense that both 
methods use an initial step to estimate the polygenic covariance and a second step to 
test for association. FASTA differs from GRAMMAR in that having estimated the 
polygenic and residual variance both are used, along with the phenotype in 
calculation of the association test statistic. 
 
Rather than using a pedigree based kinship matrix, genomic kinship matrices were 
calculated for participants within each study using identity-by-state sharing, 
weighted by allele frequency. The kinship matrix was then used in a linear polygenic 
mixed model to account to estimate the polygenic and residual environmental 
components. 
 




((g − E[g])T ⋅ (Φ⋅ ˆ σ g
2 + I ⋅ ˆ σ e
2)−1 ⋅ (Y − ˆ µ ))2
(g − E[g])T ⋅ (Φ⋅ ˆ σ g
2 + I ⋅ ˆ σ e
2)−1 ⋅ (g − E[g])
 
Where (g - E[g]) is the additively coded observed genotype minus expected average 
genotype based on allele frequency. (Φ.σg2 + I. σe2)-1 represents the inverse of the 
variance covariance matrix calculated by multiplication of the kinship matrix, Φ, by 
the estimated polygenic variance, σg2, and adding the residual environmental 
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variance, σe2, multiplied by the identity matrix, I. Y is the phenotype value and µ is 
the population mean.  
 
The FASTA method should provide suitable correction across a wide range of λ 
values and, unlike GRAMMAR; it does not rely on pedigree information. This 
makes it more versatile in that it can be applied to populations with unknown 
pedigree information. It should also theoretically give more accurate correction in 
that human pedigrees can rarely be traced beyond a handful of generations with any 
degree of accuracy, whereas the genomic kinship should always give an accurate 
reflection of the genetic relationship between two individuals. 
 
2.5 Meta-Analysis 
Meta-analysis of the association statistics was performed using an inverse variance 






ˆ β i =
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Where βij is the effect estimate for SNP i in study j,  Sij2 is the standard error squared 
and ωij is the study weighting. The meta-analysis effect estimate for each SNP is then 
calculated by multiplying each study estimate by its weighting, summing across all 
studies and dividing by the sum of all study weights. The meta-analysis standard 
error (
€ 
ˆ S i) is given by 1 over the sum of all study weights. 
 
 
2.6 Accounting for medication effects 
 
When dealing with quantitative phenotypes certain medications can alter the 
phenotype in question. For example individuals with T2D who are unable to 
maintain dietary control of their blood glucose levels may be prescribed glucose 
lowering medications(Consoli, Gomis et al. 2004) or, in more extreme cases, insulin 
injections(Mayfield and White 2004). These medications will have a substantial 
impact on the measured phenotype and would therefore interfere with the accuracy 
of our estimates of other sources of variation such as genetic loci. 
 
A variety of strategies are available to deal with the effects of medication roughly 
divided into three categories; i) ignoring the medication, ii) attempting some form of 
correction to restore the phenotypic value to the untreated level, iii) excluding 
medicated individuals prior to analyses.  
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The category of correcting for medication effects includes strategies in which the 
phenotype value of all medicated individuals is changed by some constant value or 
alternatively a statistical correction which allows for a varying level of treatment 
effect across in different individuals.  
 
A comprehensive review of strategies to deal with medication has been presented in 
the work of Tobin et al (Tobin, Sheehan et al. 2005). The recommendation of this 
work favour correction of phenotypic value either through addition of a constant 
value or using a censored normal regression model to estimate a different correction 
value for each medicated individual depending on their position in the distribution. 
 
The analysis conducted on glycaemic phenotypes in this thesis excludes all 
medicated and hyperglycaemic individuals. The method of adding a constant value to 
medicated individuals was considered, however treatment for type 2 diabetes can 
vary from diet and exercise in well controlled cases (Boule, Haddad et al. 2001), oral 
glucose lowering drugs in more severe cases(Consoli, Gomis et al. 2004; Krentz and 
Bailey 2005), or even insulin treatment in poorly controlled cases(Mayfield and 
White 2004). Highly detailed information of this type was not readily available from 
all of the studies used in this project and so this method of correction was not 
feasible.  
 
The strategy of estimating and correcting for medication effects statistically was also 
considered. There are several important considerations when using this approach 
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including the size of the sample available, the proportion of medicated individuals 
and the distribution of the phenotype. The censored normal regression method 
assumes that  
“the distribution of underlying BP above any specified value is the same in 
treated and untreated individuals”  
While this may be a valid assumption in relation to blood pressure the distribution of 
diabetes related phenotypes in our study populations was highly skewed with 
diabetic patient values being considerably higher than the normal range. The overall 
sample sizes in our studies were modest and the prevalence of diabetes in our 
populations, between 2.1 and 9.2%,was also relatively small compared with more 
widely treated phenotypes such as blood pressure. All these factors result in a very 
small amount of informative data for the censored normal regression correction 
method.  
 
In addition to data driven arguments the decision to exclude medicated and 
hyperglycaemic individuals from our analysis was also guided by the strategy of 
previous studies. The exclusion of known diabetics in studies of related quantitative 
phenotypes has become common practice(Meigs, Manning et al. 2007; Chen, Erdos 
et al. 2008; Pare, Chasman et al. 2008; Bouatia-Naji, Bonnefond et al. 2009; 
Prokopenko, Langenberg et al. 2009; Dupuis, Langenberg et al. 2010).    
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3 Chapter 3: Linkage meta-analysis of fasting glucose in 
four isolated populations 
The first analysis attempted in this project was a genome-wide linkage analysis of 
Fasting Glucose (FG) levels in the four EUROSPAN populations described below 
with appropriate marker and phenotype data available. Blood glucose levels vary 
greatly in response to the intake of food and some beverages so FG measures taken 
after an overnight fast are a more stable measure of baseline blood glucose. 
 
Generally speaking, highly polygenic quantitative phenotypes may not be expected 
to yield strong results using the linkage analysis method since, as previously noted, 
the method has weak power to detect variants with small individual effect sizes. 
However, the existence of at least 10 forms of monogenic diabetes (Craig, Hattersley 
et al. 2006) may provide more reason for hope. While the mutations responsible for 
monogenic forms result in early onset of diabetes and the related breakdown of 
glycaemic control, alternate polymorphisms at the same loci may produce less severe 
functional consequences, which on their own are not fully penetrant but may 
contribute to the development of T2D in concert with other genetic or environmental 
factors. A second, practical reason for conducting linkage analysis is that it makes 
use of the large amounts of family structure inherent in any isolated population 
study.  
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The four populations were tested for linkage separately and the test statistics were 
combined using meta-analysis to give an overall measure of evidence for linkage. 
Regions that showed suggestive evidence of linkage for FG, either in a single 
population or in the meta-analysis, were subsequently tested in a candidate region 
association analysis using high density SNP data. 
 
The theoretical rationale for this candidate region analysis was that; while linkage 
analysis is most powerful in the detection of rare, strong variants and association 
analysis is most powerful for detecting common variants, a true FG locus may show 
marginal evidence in both analyses. On the other hand a false positive finding arising 
from some problem with the linkage markers would be unlikely to show independent 
association evidence in the SNP data. 
 
3.1 Description of populations/markers for ERF, MICROS, 
NSPHS and VIS Populations 
 
Four of the EUROSPAN populations originating from Sweden, Italy, Croatia and the 
Netherlands had genotype data designed for the purposes of linkage analysis. 
 
The Swedish samples are part of the Northern Swedish Population Health Study 
(NSPHS) representing a family-based population study including a comprehensive 
health investigation and collection of data on family structure, lifestyle, diet, medical 
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history and samples for laboratory analyses (Johansson, Vavruch-Nilsson et al. 
2005). The samples used for linkage analysis were collected from the southern part 
of the Swedish mountain region in the county of Västerbotten. Historic population 
accounts shows that there has been little immigration or other dramatic population 
changes in this area during the last 200 years. In total 436 individuals were 
genotyped for 390 microsatellite markers. 
 
The Italian population subjects were sampled from a study of microisolates in south 
Tyrol (MICROS). Study participants were volunteers from three isolated, German-
speaking villages, located in a region bordering with Austria and Switzerland 
(Pattaro, Marroni et al. 2007). Due to geographical, historical and political reasons, 
the entire region experienced prolonged isolation from surrounding populations. The 
investigated population is characterized by an old settlement, a small number of 
founders, high endogamy rates, slow or null population expansion and negligible 
immigration. An extensive genealogy spanning 12 generations was available for this 
study. A total of 926 individuals from this population were genotyped at 1,113 
microsatellite markers. 
 
The Croatia population (VIS) consists of unselected Croatians aged 18–93 years 
recruited into the study from the villages of Vis and Komiza on the Dalmatian island 
of Vis who were phenotyped for >50 disease-related quantitative traits. The genetic 
isolation of the villages from the Croatian mainland and from surrounding islands 
has been confirmed (Vitart, Biloglav et al. 2006) and this population has already 
Linkage and Association Mapping for Quantitative Phenotypes in Isolated Populations 
 
 41 
yielded novel and replicated quantitative trait loci(Vitart, Rudan et al. 2008). 747 
microsatellites were genotyped in 591 members of the VIS study. 
 
The Dutch samples are from the Erasmus Rucphen Family (ERF) study, which was 
carried out on a Dutch isolated population located in the Southwest of the 
Netherlands. This community was founded in the middle of the 18th century by 
approximately 150 individuals and was isolated until the last decades. It is 
characterized by rapid growth and minimal inward migration and has now expanded 
up to 20,000 inhabitants (Aulchenko, Heutink et al. 2004). Within this population, a 
specific subpopulation based on 20 couples (selected on the basis that they had at 
least 6 children baptized in the community church between 1880 and 1900) has been 
defined. All living descendants of the selected couples and their spouses (n≈3,000) 
have been recruited, basically forming one single extended pedigree. The ERF study 
samples were typed at a set of 6,008 SNPs designed for genome wide linkage 
analysis. A total of 1,455 ERF samples were genotyped making this by far the largest 
population. 
 
The use of different genotype panels in these studies raises several issues. The 
considerably large number of markers used in the ERF study is indicative of the 
reduced information content of SNP markers when compared to microsatellites. 
SNPs are predominantly bi-allelic and, even in cases when 3 or 4 alleles exist; the 
duel fluorescence microarray assay used to type them assumes this bi-allelic state. 
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By contrast the microsatellite markers used in the other studies have up to 14 distinct 
alleles making the differentiation of IBS and IBD considerably easier. 
 
A second issue that arose within the microsatellite-based analyses was the genetic 
map position of markers. The linkage analysis requires marker positions to be 
assigned according to recombination distances between markers rather than physical 
base-pair position. These recombination distances are calculated within a population 
by observation of crossover events within pedigrees and; since larger studies will 
give more accurate estimates of recombination distance, a number of standardized 
recombination maps have been published(Murray, Buetow et al. 1994; Dib, Faure et 
al. 1996; Broman, Murray et al. 1998; Kong, Gudbjartsson et al. 2002). 
 
The VIS and MICROS marker positions were based on the Decode recombination 
map(Kong, Gudbjartsson et al. 2002) while the NSPHS markers positions were 
assigned according to the older Marshfield map (Broman, Murray et al. 1998). To 
converge all marker data to the same genetic map we replaced the Marshfield 
positions with Decode positions in the NSHPS data wherever a marker was reported 
on both maps. In cases where a marker was not present on the Decode map we used 
the two nearest flanking markers for which Decode and Marshfield positions were 
available to interpolate an approximate Decode position.  
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3.2 Pedigree Splitting 
Large pedigrees are desirable when conducting a linkage analysis, however the 
computational requirements for calculating multipoint IBD (mIBD) estimates 
increases exponentially with pedigree size. The size and complexity of the pedigrees 
obtained for the EUROSPAN populations was such that mIBD estimates could not 
be obtained with the resources available at the time. To overcome this problem the 
pedigrees were split into multiple sub-pedigrees using the PedStr software 
(Kirichenko, Belonogova et al. 2009) with a maximum bit size of 18 individuals, 
where bit size is twice the number of non-founders minus the number of founders 
within the sub-pedigree. 
 
3.3 IBD calculations using multipoint engine for rapid 
likelihood inference (MERLIN) 
Having obtained sub-pedigrees of an appropriate size the mIBD matrices were 
calculated for each population using the MERLIN software (Abecasis, Cherny et al. 
2002). Splitting the pedigrees gives a slightly reduced estimate of pedigree-based 
kinship between individuals, which will in turn cause an underestimation of mIBD. 
To correct for this we calculated single marker IBD estimates, took a genome-wide 
average and used this as an inflation factor for the mIBD estimates. 
 




FG levels were available for the majority of samples within each of the 4 studies 
described. Individuals with known diabetes diagnoses or who had FG values above 
7mmol/l were excluded from analysis so that FG variation in the healthy population 
could be tested. 
 
The proportion of samples excluded for diagnosed or suspected diabetes varied 
considerably between the four studies with a maximum of 7.6 % from the ERF study 
and minimum of 2% from the NSPHS study. Within the non-diabetic populations 
there was still a great deal of variation in the distributions of relevant measures. 
Table 1 shows the mean and standard deviations for age, BMI and FG levels in the 
four populations. This phenotypic heterogeneity coupled with the genetic 
heterogeneity between separate populations is the major rationale for using a meta-
analysis rather than pooled analysis study design. 
 
Table 1. Descriptive statistics for populations used in linkage analysis, mean 
(standard deviation) 
Population N Age (yrs) BMI (kg/m2) FG (mmol/l) 
ERF 1455 52 (16.0) 26.8 (4.6) 4.6 (1.02) 
MICROS 926 46 (16.6) 25.6 (4.5) 4.7 (0.92) 
VIS 591 56 (16.3) 27.1 (4.1) 5.7 (1.48) 
NSPHS 436 45 (11.6) 25.8 (3.8) 5.1 (1.17) 
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3.5 Linkage analysis using Sequential Oligogenic Linkage 
Analysis Routines (SOLAR) 
The estimation of trait heritability and linkage analysis was performed using the 
SOLAR software package (Almasy and Blangero 1998). This package has its own 
methods for calculating mIBD matrices but, while computationally efficient for large 
pedigrees, the mIBD values obtained are approximate. The alternative MERLIN 
algorithm we chose to use gives exact mIBD values. Although using split pedigrees 
is itself an approximation to the true underlying IBD, the MERLIN method applied 
to split pedigrees captures all close familial relationships while running considerably 
faster than SOLAR. 
 
The SOLAR program outputs an estimated heritability for the trait being analyzed 
and a list of LOD-score test statistics denoting evidence for linkage at the specified 
map positions. The meta-analysis test statistic was simply the sum of the individual 
study statistics at each position. For the purposes of assessing significance in the 
meta-analysis it is important to note that the SOLAR linkage analysis constrains the 
output LOD-score to a minimum of zero, i.e. no evidence against linkage is given. 
This results in a general inflation of the meta-analysis results and so requires a higher 
significance threshold. 
 
To define our significance thresholds we used the relationship that a LOD score 
multiplied by twice the natural log of 10 (2xloge(10)) is approximately equivalent to 
a χ2 value (Lander and Kruglyak 1995). Using a p-value of 5x10-4 and 1 degree of 
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freedom gives a LOD threshold for a single study of 2.63. For the meta-analysis the 
same p-value with 4 degrees of freedom gives a threshold of 4.34.  
 
3.6 Results 
The narrow sense heritability estimate for each study calculated using SOLAR is 
given in Table 2. In terms of accuracy the larger studies would be expected to give 
estimates closer to the true genetic heritability. Within our study populations the two 
largest studies, ERF (N=1455) and MICROS (N=926), give the smallest (0.3) and 
largest (0.5) estimates respectively. A previous extremely large study of a Sardinian 
population isolate gave an estimated serum glucose heritability of 0.36 (Pilia, Chen 
et al. 2006) consistent with the ranges we see here. As previously mentioned the 
heritability estimates are population specific and there are several possible 
explanations for the wide range of estimates obtained for these four studies. 
 
Firstly environmental variance will be affected by the variability, or lack thereof, of 
diet and physical activity within each study population. Secondly the accuracy of the 
measurement method used in each study site and the consistency of the measurement 
protocol will result in variable levels of error variance for each study. Thirdly there 
may theoretically be polymorphic loci that influence FG levels segregating in one or 
more of the study populations that are fixed in the other populations. It is most likely 
that a combination of these factors is responsible for the variable estimates but the 
most important fact is that all studies show a substantial genetic component for FG 
levels indicating that there are indeed loci to be identified. 




Table 2. Narrow sense heritability estimates for FG levels using SOLAR 
Population N FG mmol/l mean (SD) Heritability (h2) 
ERF 1455 4.6 (1.02) 0.30 
MICROS 926 4.7 (0.92) 0.50 
VIS 591 5.7 (1.48) 0.41 
NSPHS 436 5.1 (1.17) 0.43 
 
The genome wide multipoint linkage analysis results for each of the four study 
populations individually and the combined meta-analysis result are shown in figure 
4. The results from single population analysis show a single peak that reaches the 
threshold for significance. The peak, on the q arm of chromosome 17, is significant 
in the ERF population while being almost completely absent in the other three study 
populations.  
 
Examination of the meta-analysis results shows no statistically significant results but 
several other peaks on chromosomes 3,4,5,7 and 19 were included in subsequent 
analysis because they contained modest but consistent linkage signals from multiple 
populations.  
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Figure 4.  Genome-wide linkage meta-analysis for FG in 4 populations 
 
For the purposes of candidate region association analysis we defined linkage peaks 
by subtracting 2 LOD points from the highest value of a peak and including the 
flanking regions with scores above this value. The size of each of the selected 
regions and the number of genotyped SNPs are shown in table 3. 
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Table 3. Linkage regions for FG and the number of SNP markers available 
within each peak for candidate region association. 
Chromosome Peak Position (cM) Width (cM) Number of SNPs 
3 162 48 5287 
4 102 20 2506 
5 205 16 752 
7 188 62 3178 
17 111 18 1287 
19 61 21 1448 
 
Collaborators from each study group conducted genotypic association tests for the 
SNPs identified in each candidate region. The total number of SNPs tested in this 
candidate region analysis was 14,458 giving a significance threshold of 3.5x10-6. The 
majority of regions tested showed no evidence for association at or close to this 
significance threshold in any of the individual studies. The peak on chromosome 19 
showed strong association with marker rs11668501 in the ERF study along with 
weaker association with several flanking markers as shown in table 4. 
 
Table 4. Chromosome 19 linkage peak candidate region association results in 
ERF study. 
SNP Chr Position (mb) Effect AB Effect BB P-value MAF 
rs3865452 19 45.90 -0.04 0.13 0.01 0.45 
rs2604913 19 45.91 -0.05 0.15 0.0022 0.42 
rs890934 19 45.92 -0.05 -0.04 0.01 0.41 
rs11668501 19 45.92 -0.02 1.06 1.2x10-8 0.12 
rs3745216 19 45.94 -0.03 0.13 0.01 0.44 
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Two of the regions identified in this study have been previously identified in linkage 
studies of glucose levels or T2D status (Figure 5). A comparable meta-analysis found 
significant linkage for fasting glucose on chromosomes 7q36 and 19q13 (An, 
Freedman et al.), which overlap with the peaks found in our study.  The q-arm of 
chromosome 7 has also shown suggestive evidence of linkage for T2D in Pima 
Indians (Imperatore, Hanson et al. 1998). 
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No significant linkage evidence was found on chromosome 10q in the region of the 
TCF7L2 gene, which has been identified in many independent populations, both by 
linkage and association analysis, as a significant risk locus for T2D.  
 
The most significant linkage result, on chromosome 17q in the ERF study, has not 
shown consistent evidence in previous studies of T2D of fasting glucose levels 
however it has been implicated in the rarer monogenic form of diabetes Maturity 
Onset Diabetes of the Young (MODY) and designated MODY5. There are a number 
of candidate genes in this region that could affect glucose homeostasis including 
TCF2.  
 
An alternative approach not taken forward in this project is the analysis of 
phenotypic extremes as a binary phenotype. Our chosen strategy involved the 
removal of medicated diabetics and observed hyperglycaemic individuals. In an 
extreme analysis strategy these individuals would be grouped together as a set of 
cases. A second subset of the population can then be taken from the opposite end of 
the phenotypic distribution to act as controls.  
 
Selecting phenotypic extremes has been proposed as should provide enrichment for 
alleles with large effects (Carey and Williamson 1991). This is particularly useful 
when applied prior to genotyping as the phenotypically selected sample can provide 
greater power than an unselected sample of equivalent size(Allison 1997). In the case 
of our studies pre-selection of samples for genotyping based on phenotype was not 
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practical as the studies were designed to investigate a wide range of traits. Given this 
fact an analysis of phenotypic extremes would allow us to retain the diabetic and 
hypoglycaemic samples but would simultaneously remove the information provided 
by genotyped samples in the middle of the phenotypic distribution. 
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4 Chapter 4: Genome-wide association of glycaemic traits in 
three to five isolated populations 
4.1 Background on hyperglycaemia/Type II diabetes 
genetics 
 
Diabetes is characterized by one or more of impaired fasting glucose, impaired 
glucose tolerance, defective insulin secretion or defective insulin action. T2D is a 
common complex disease characterized by impaired fasting glucose (IFG) and/or 
impaired glucose tolerance (IGT) as defined using criteria endorsed by the world 
health organization (WHO 2006). A fasting plasma glucose level above 7mmol/l on 
two separate occasions is considered diagnostic for T2D. Chronic hyperglycaemia 
can lead to serious complications including nephropathy, neuropathy, retinopathy 
and increased risk of cardiovascular disease (Grant, Thorleifsson et al. 2006). The 
total number of diabetes sufferers worldwide was estimated at over 171 million for 
the year 2000 and is predicted to rise to 366 million by the year 2030(Wild, Roglic et 
al. 2004). 
 
Environmental factors known to influence T2D risk include central obesity and a 
lack of physical exercise. Recent increases in the prevalence of T2D are likely to be 
due to the increased prevalence of adverse lifestyle factors, ageing of populations 
and improved survival, however T2D also shows a significant genetic component 
with a sibling risk ratio of 3.5 (Weijnen, Rich et al. 2002).  It has been suggested that 
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genetic mapping of a disease as complex and heterogeneous as T2D is inappropriate 
and that study of the quantitative traits underlying the disease may be more 
productive(Bougneres 2003). However in recent years studies of T2D using case 
control designs have successfully identified and replicated 37 T2D susceptibility loci 
demonstrating that, with sufficiently powered studies, the genetics of heterogeneous 
diseases and phenotypes can be studied in this way (Sladek, Rocheleau et al. 2007; 
Ng, Park et al. 2008; Zeggini, Scott et al. 2008; Bouatia-Naji, Bonnefond et al. 2009; 
Voight, Scott et al. 2010). 
 
Several biochemical traits are relevant to T2D. FG levels are commonly used as a 
diagnostic tool in suspected T2D cases with levels above 7 mmol/L being suggestive 
of T2D. Glycosylated haemoglobin (HbA1C) is used to monitor blood glucose levels 
over the complete life cycle of the red-blood cells, approximately 8-12 weeks. This 
makes the trait ideal for monitoring the health of T2D patients and it is also 
increasingly used as a diagnostic test for T2D to obviate the need to collect a fasting 
sample or administer a 2-hour glucose challenge test. Insulin levels are also a key 
component of glucose homeostasis and can be used along with FG levels to compute 
the Homeostasis Model Assessment phenotypes HOMA-IR (Insulin Resistance) and 
HOMA-B (Beta-cell function) (Matthews, Hosker et al. 1985). 
 
One of the first major genetic risk factors to be discovered for T2D is the TCF7L2 
locus that was identified through association mapping within a region previously 
identified through linkage on chromosome 10q1. This association has been 
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consistently replicated across a diverse range of populations (Kimber, Doney et al. 
2007; Sladek, Rocheleau et al. 2007; Herder, Rathmann et al. 2008; Ng, Park et al. 
2008; Roth, Hinney et al. 2008; Sanghera, Ortega et al. 2008). 
 
More recently high density Single Nucleotide Polymorphism (SNP) genotyping has 
allowed the development of genome-wide association (GWA) strategies, which can 
identify QTLs in linkage disequilibrium (LD) with a SNP marker within a population 
rather than relying on segregation of markers and QTLs within a family. Whilst 
linkage analysis is useful for detecting rare variants with large effects the GWA 
approach can detect more common variants with smaller individual effect sizes.  
 
Many GWA scans have been carried out for T2D with considerable success, and at 
least 38 reproducible associations with small individual effect sizes have been 
identified(Lango, Palmer et al. 2008; Voight, Scott et al. 2010). Additionally as 
people recognise the benefits of studying quantitative traits a number of GWA scans 
have begun to study glucose, insulin and HbA1C   as quantitative traits.  
 
The Framingham heart study published one of the first GWA studies on diabetes 
related quantitative traits and were unable to identify any associations which reached 
a genome-wide significance level after correcting for the number of tests 
performed(Meigs, Manning et al. 2007). However the study had a limited sample 
size of just over 1000 individuals and a relatively sparse 100k SNP marker panel 
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which, in light of the effect size of variants now known to be involved in these 
phenotypes, was greatly underpowered. 
 
More recently collaborative efforts between many smaller studies have produced 
convincing, replicated associations. Chen et al (2008) used an initial sample of 5k 
non-diabetic Finnish and Sardinian individuals and a replication sample of over 18k 
European individuals to study FG levels (Chen, Erdos et al. 2008). They identified a 
region between the G6PC2 and ABCB11 genes that was strongly associated (p=6.4 x 
10-33) with FG.  
 
A later study using French non-diabetic individuals identified the MTNR1B 
melatonin receptor gene as having a role in FG levels (Bouatia-Naji, Bonnefond et 
al. 2009). This study had a relatively small discovery cohort of 2,151 samples and 
produced two significant associations after correction for multiple testing. Only one 
of the markers replicated consistently across four replication cohorts totaling over 16 
thousand samples suggesting that the other result may have been a false positive 
despite having a considerably more significant p-value (8x10-9 and 1.3x10-7 
respectively). 
 
The most recently, and to date the largest, published GWA meta-analysis study 
conducted on FG was by the Meta-Analysis of Glucose and Insulin-related traits 
Consortium (MAGIC) (Prokopenko, Langenberg et al. 2009). The first stage of this 
collaboration included a total of 33,321 healthy individuals of European descent and 
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2,688 diabetics. The study provided extremely strong replication of the previously 
identified effects of MTNR1B, G6PC2 and the gluco-kinase receptor (GCK) on FG 
levels. The study also looked at the effect of identified FG risk alleles on T2D risk 
but found no significant effect. A second phase of the MAGIC collaboration was 
published during the writing of this thesis and includes analysis of data for over 109 
thousand individuals (Dupuis, Langenberg et al. 2010).  
 
Studies with such large sample sizes should be capable of detecting the common 
variants with small effect sizes that are predicted to make up the majority of genetic 
variance in complex disorders. It is however still possible that a rare variant which 
may be at a low frequency, or non-polymorphic, in some populations could be 
identified in an isolated population where it may have drifted to a higher frequency. 
A number of the studies involved in the collaborative meta-analyses were designed 
for just that purpose. The problem in these cases is that replication becomes more 
difficult and if an association fails to replicate it is not usually pursued any further.  
  
The isolates used in this study have had small stable population sizes for long periods 
resulting in reduced allelic heterogeneity and stronger linkage disequilibrium than is 
found in cosmopolitan populations (Wright, Carothers et al. 1999). The reduced 
genetic and environmental variance in populations of this type should improve 
identification of variants with small effect sizes. 
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4.2 Description of populations/SNP markers for ERF, 
MICROS, Vis, KORČULA, ORCADES 
The data sets used for association analysis partially overlapped with the data sets 
previously used in the linkage analysis with the MICROS, ERF and VIS samples 
used for both linkage and association analysis. One additional EUROSPAN project, 
the Orkney Complex Disease Study (ORCADES), was added to the analysis at the 
GWAS stage and a further population isolate from the Dalmatian island of Korčula 
(KORČULA) was available for association analysis. 
 
The ORCADES project is an ongoing family-based cross-sectional study in the 
isolated Scottish archipelago of Orkney. Genetic diversity in this population is 
decreased compared to Mainland Scotland, consistent with the high levels of 
endogamy historically.  Data for participants aged 18-100 years with ancestry from a 
subgroup of ten islands, were used for this analysis. Fasting blood samples were 
collected and over 200 health-related phenotypes and environmental exposures were 
measured in each individual. All participants gave informed consent and the study 
was approved by Research Ethics Committees in Orkney and Aberdeen. A total of 
719 ORCADES samples passed quality control and were used in the association 
analysis. 
 
The VIS study as previously described consists of samples from two villages on the 
island of Vis with known reduced genetic diversity. A larger number of samples 
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were genotyped for association analysis and, after quality control, a maximum of 795 
samples were used. 
 
The ERF samples typed with genome wide SNP coverage represent a subset of those 
used for linkage analysis. After quality control a maximum of 918 samples were 
available for association analysis.  
 
The MICROS samples used in the association analysis are also from the same study 
population used in the linkage analysis. A total of 1097 samples had genome-wide 
SNP data.  
 
The KORČULA project followed on from the VIS project using a similar study 
design to collect samples from a second Dalmatian island, Korčula. A vast range of 
anthropometric, biochemical and psychometric measurement were collected as well 
as information on medical history and various lifestyle factors with relevance to one 
of more of the measured phenotypes. Quality controlled genotype data was available 
for a total of 888 KORČULA samples. 
 
4.3 Quality Control of Genome-wide SNP data 
 
Proper Quality Control (QC) of large-scale SNP genotype data is important for 
avoiding large numbers of false-positive and false negative association results that 
may arise due to errors in genotyping or the presence of population 
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stratification(Cardon and Palmer 2003; Anderson, Pettersson et al. 2010; Weale 
2010). Accuracy of genotype data is also of relevance to down-stream data 
applications such as imputation wherein a badly called SNP may be used to infer 
information about hundreds of additional untyped variants, although imputation 
procedures have been shown to be reasonably robust with respect to standard QC 
protocols(Southam, Panoutsopoulou et al. 2011). 
  
The initial wave of data for the ORCADES project provided genotype data for a total 
of 761 samples. The first check performed on this data was to assess the genetic sex 
of each individual’s X chromosome SNP data to calculate an inbreeding coefficient 
F. In females the X chromosome F should be close to the coefficient for autosomal 
data, though slightly higher due to the reduced effective population size for the X 
chromosome. As males only carry a single X chromosome all X-linked SNPs should 
appear homozygous in males resulting in an inbreeding coefficient of 1(Weale 2010). 
Having obtained a predicted genetic sex we then cross-reference this with the 
reported sex for that sample. While there are circumstances, such as X chromosome 
aneuploidy or gender reassignment, that could result in the reported and genetic 
genders conflicting it is more likely in these cases that mislabeling of a DNA sample 
or some other identifier error has occurred and the genotype sample and phenotypic 
data cannot be confidently linked to one another. So in these gender mismatch 
scenarios the sample must be excluded from further analysis. This sex-check 
excluded 9 samples from the ORCADES data set. 
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Individuals with poor quality genotype data can be identified by their genotype call 
rate and/or their average heterozygosity as shown in figure 6. An individual with low 
average call rate may represent a low concentration or degraded DNA sample and 
the genotypes that are called in these individuals may therefore be unreliable.  
 
The average genome-wide heterozygosity of a sample can identify unusual samples 
in a number of ways. Individuals with unusually high heterozygosity may result from 
population admixture and so would be unrepresentative of the population being 
studied. Alternatively extremely high heterozygosity may result from contamination 
of the DNA sample, which clearly means the genotypes are not accurate(Weale 
2010). In the opposite instance of unusually low heterozygosity the explanation is 
likely to be either increased parental relatedness of the individual resulting from past 
inbreeding events and a proportionally inflated level of IBD across the genome or 
poor quality DNA.  
 
To define and exclude samples that may adversely affect analysis we used a 
genotype call rate of 98% as shown by the vertical line in figure 6, 27 individuals fell 
below this threshold. Within these 27 samples, 2 also had heterozygosity more than 
3s.d above the population mean and were excluded. Individuals with good call rate 
but unusually low heterozygosity were not excluded because the use of an isolated 
population increases the levels of background inbreeding and so we expect these low 
heterozygosity values to be the result of increased parental relatedness rather than 
poor quality DNA samples. 
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Figure 6. Individual call rate and heterozygosity values for ORCADES individuals retained in 
association analyses. Vertical line represents call rate of 0.98. Horizontal lines are +/- 3s.d from 
population mean heterozygosity. 
 
 
Association analysis is also sensitive to the relationships between samples and in 
particular twin or duplicated samples can introduce false positive results. 
Identification of genetically identical samples was performed by calculating the 
identity by state (IBS) levels of a random subset of 2000 autosomal SNP markers and 
identifying pairs of samples that had excessively high allele sharing at these markers. 
The mean IBS in the ORCADES samples was 0.72 (s.e. 0.009) and a threshold of 
0.95 was used to identify a total of 3 pairs of duplicate samples. In each of these 
cases one of the pair of individuals had already been marked for exclusion based on 
call rate. 




Lastly we identified samples that were genetically too distant from the majority of 
the population. This was initially carried out by multidimensional scaling (MDS) of 
IBS distances. The majority of samples within a population should form a single 
cluster while samples with different ethnic backgrounds will have consistently lower 
IBS and will stand out from the rest of the population. The MDS analysis identified a 
further 6 individuals for exclusion.  
 
4.3.1 Principle Components Analysis (PCA) of study populations 
To confirm the quality control results obtained with simple MDS we subsequently 
analyzed the clean data set using more versatile PCA methods. This was done firstly 
to confirm the European ancestry of our ORCADES samples and subsequently, when 
moving into meta-analysis, to explore the finer scale ethnic differences between the 
ORCADES population and the other study populations from the EUROSPAN 
consortium and the KORČULA project 
 
For the first broad scale ethnic check we used the phase 3 samples from the HapMap 
project (2003) as an ethnically diverse training data set for the PCA analysis. This 
means that the weightings for the SNPs that make up the major principle components 
(PCs) are chosen based on differences between the ethnically diverse HapMap 
populations rather than our own populations. The construction of the PCs is sensitive 
to the interrelatedness of samples and to extended regions of strong LD so only 
unrelated HapMap samples were included and a set of known long LD chromosome 
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regions were removed prior to analysis (Price, Patterson et al. 2006). A subset of 
SNPs that were also typed in our study samples was then extracted and the Eigenstrat 
SmartPCA program (Price, Patterson et al. 2006) was used to identify SNPs that best 
describe the differences between ethnic groups. These SNPs are then used to identify 
the ethnic origin of our samples. Those who do not cluster with the European 
HapMap populations and the rest of the sample set can be excluded prior to analysis. 
 
The results of the supervised PCA (figure 7) show that no ethnic stratification was 
found in the ORCADES study and the samples correspond as expected to European 
descent. 
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Figure 7. Supervised PCA showing ethnic origin of the ORCADES population 
 
 
PCA can also be used to explore the more fine scale differences between our separate 
study populations. As with the HapMap analysis, closely related individuals may 
result in distortion of the major principle components and, since in this case the study 
populations are being used to define the PCs, the closely related individuals must be 
removed. To achieve this, genome-wide IBD estimates were calculated using PLINK 
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(Purcell, Neale et al. 2007). The average proportion of sites shared IBD between two 
individuals can then be used to estimate how closely related those samples are to one 
another, e.g. the expected proportion for full siblings is 0.5, half siblings 0.25 and 
first cousins 0.125.  
 
To prune the close relationships from our populations we excluded one of each pair 
of samples with a proportion of IBD greater than 0.1. The remaining unrelated 
samples from each of the five populations were then combined. As with the HapMap 
supervised analysis regions of extended LD were excluded prior to running the PCA. 
 
The results (figure 8) demonstrate that while all the study populations are European 
in ancestry there are still substantial genetic differences between populations. The 
first PC shows divisions between the northern European populations (ORCADES 
and ERF) and the southern European populations (VIS and KORČULA), the second 
PC shows separation between the two Dalmatian islands and the third PC shows 
some separation of the ORCADES and ERF populations. These differences make a 
pooled analysis unwise.  
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Figure 8. Unsupervised PCA showing 3-dimentional separation of the 5 study populations used 
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4.3.2 Comparison of association methodologies 
The inter-relatedness of the participants within each of our study populations will 
result in a large amount of phenotypic correlation between relatives due to the shared 
genetic background and heritability of the traits. This covariance would result in 
inflated evidence for association with a large number of markers which were 
segregating within a family but which have no actual influence on the traits in 
question, i.e. false positive results. To control for this effect we can use a relationship 
matrix to estimate the proportion of phenotypic variance which is due to shared 
genetic background. We can then use residual phenotypic values excluding this 
polygenic variance to test for association with an individual marker. 
 
The majority of the studies being used here have collected large amounts pedigree 
information on their respective participants meaning that, along with genotypic 
information, we have two alternative sources of relationship information.  
 
Kinship matrices based on known pedigree information are relatively simple to 
calculate and have been in use for a long time both in human and animal genetic 
research. The kinship score between two individuals represents the expected 
proportion of the genome, which will be shared identical-by-descent (IBD) between 
the related individuals. This is an average figure for a given pedigree relationship and 
the true level of sharing can be considerably larger or smaller due to the random 
nature of crossing over during meiosis. 
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With high density SNP data covering essentially the whole genome it is possible to 
estimate the level of genetic relatedness between two individuals based on their 
identity-by-state (IBS) sharing. By calculating the observed allele frequencies within 
our populations at each locus we can estimate the average proportion of all loci that 
we would expect to be shared between two unrelated individuals within that 
population. Shared ancestry will result in excess allele sharing and the degree of 
sharing can be used to estimate how closely the two individuals are related. Kinship 
matrices generated using this method can therefore give a more accurate estimate of 
the proportion of phenotypic variance due to polygenic effects. As an example of the 
differences in kinship that are revealed using this genomic estimator, sibling pairs on 
average share 50% of their genomes IBD, however the realized sharing for siblings 
in the ORCADES study varied between approximately 38% and 62%. 
 
As a baseline for comparison of the alternative correction methods an initial analysis 
of FG, with age sex and BMI as covariates, was performed. The FG phenotype was 
rank-transformed prior to analysis to give an appropriate normal distribution. The 
results for this uncorrected analysis are shown in figure 9. The λ inflation of these 
results is approximately 1.09. Using genomic control to correct for this inflation 
gives the results shown in figure 10. As the same inflation factor is applied to all 
tests the relative ranking of SNPs is unchanged by GC and only the magnitude of the 
P-values is altered. 
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Figure 9. GWAS for ORCADES FG levels with age sex and BMI as covariates 
 
Figure 10. GWAS for ORCADES FG levels after GC correction with λ=1.09 
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Figure 11 shows the QQ plots for these uncorrected and GC corrected GWAS 
results. The λ value of 1.09 reflects a considerable level of inflation across the entire 
range of test statistics.  
 
Figure 11. QQ plot of Uncorrected and GC corrected P-values for ORCADES FG levels 
 
The results obtained under the GRAMMAR methodology are shown in figure 12. 
The results profile changed considerably under this model with the most significant 
SNP result from the GC analysis greatly reduced while other markers have become 
considerably more significant. The QQ plot of the GRAMMAR analysis (figure 13) 
shows that a lower level of inflation is still present, with a λ value of 1.05. 
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 Figure 12. GWAS for residual FG levels after correction for pedigree based kinship.  
Figure 13. QQ plot of ORCADES FG results under the GRAMMAR method 
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The results obtained using the FASTA method are shown in figure 14. The resulting 
QQ distribution (figure 15) from this analysis showed no evidence of overall 
inflation with a λ value of 0.99. 
 
Figure 14. GWAS results for ORCADES FG using genomic kinship correction under the 
FASTA methodology 
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Figure 15. QQ plot of ORCADES FG results using FASTA 
 
Finally, figure 16 compares the QQ plots of all the investigated correction methods. 
The relative λ values of 1.05 and 0.99 obtained using the GRAMMAR and FASTA 
methods respectively suggests that the genomic kinship correction step implemented 
in FASTA was more successful in breaking down the correlation between overall 
relatedness and phenotypic covariance, and was therefore less likely to produce 
spurious results or overly inflated effect estimates based on the population structure 
present in the ORCADES study. 
 
Additionally, the use of the FASTA methodology, which does not require pedigree 
data, allowed for the use of standardized analysis methods when meta-analyzing 
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results including the KORČULA study for which no pedigree information was 
available. 
 
Figure 16. QQ plot comparing ORCADES FG results obtained using GC, GRAMMAR or 
FASTA correction methods 
 
 
4.4 Meta-analysis Results 
Having chosen the FASTA method of analysis based on the ORCADES population, 
the diabetes-related phenotypes were tested for association in several further 
population isolates and meta-analysis was performed. The populations used are 
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described fully in the materials and methods chapter. In total there were 3 measured 
biochemical phenotypes, fasting glucose (FG), fasting insulin (FI) and HbA1C. A 
further 2 phenotypes were derived from the ratio and product of FG and FI to give 
measurements of insulin resistance (HOMA-IR) and beta cell function (HOMA-B). 
HOMA-IR was calculated as (FG mmol/l * FI microunits/l)/22.5. HOMA-B was 
calculated as (FI microunits/l * 20)/(FG mmol/l - 3.5) (Matthews, Hosker et al. 
1985). 
  
Not all of the study populations had measured all 3 of the biochemical phenotypes so 
the number of samples, and the related power for association, for each analysis 
differs substantially. FG was available in the ORCADES, VIS, ERF, MICROS and 
KORČULA populations giving a combined sample of 4417 phenotyped individuals. 
FI and the derived HOMA traits were available in the ORCADES, VIS, and ERF 
populations totaling 2432 samples. HbA1C was available in the ORCADES, VIS and 
KORČULA populations with a total sample size of 2402.  
 
ORCADES biochemical measurements were from gel-separated serum or whole 
blood samples taken between 8am and 9:30am after fasting from 10pm the previous 
night. The samples were taken to the biochemical lab within 2 hours of being drawn 
and were run through a Beckman Coulter UniCel DxC600i analyzer. The coefficient 
of variation for the FG assay was 3.8% and the sensitivity of the FI assay was 0.03 
uIU / ml. The HbA1C measurements were taken from whole blood and were aligned 
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to the International Federation of Clinical Chemistry (IFCC) standards (Manley, 
John et al. 2004).  
 
VIS measurements were from gel-separated serum or whole blood drawn between 
8am and 9am after overnight fast. The samples were allowed to clot for 30 minutes 
before being centrifuged, aliquoted and stored at -70 degrees Celsius. The FG 
measures were obtained using UV hexokinase photometry and FI measurements 
were obtained using the ECL1A electrochemiluminescence immunoassay from 
Cobas. The sensitivity of this assay is 0.02 uIU / ml. The HbA1C measurement were 
obtained by immunochemistry electrophoresis according to Diabetes Control and 
Complications Trial (DCCT) standards (1986). 
 
The ERF samples were taken after overnight fast, serum separated and immediately 
frozen. The FG measurements were obtained from hexokinase assay using a 
Synchron LX20 and the FI measurements were from a Biosource INS-Irma kit. This 
assay has a reported sensitivity of 1 uIU / ml.  
 
The MICROS samples were drawn from blood plasma after overnight fast between 
the hours of 7am and 9:30am and were taken to the biochemical lab within 3 hours. 
The FG measurements for this study were obtained using a hexokinase assay on a 
Dimension RxL. 
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The KORČULA FG measurements were obtained from gel separated serum or whole 
blood samples taken after overnight fast and were assayed by hexokinase 
photometry. An HbA1C immunochemical electrophoresis assay was used and the 
results were aligned to the DCCT guidelines. 
 
As HbA1C levels were measured and reported according to IFCC guidelines in the 
ORCADES study and the measurements for the VIS and KORČULA studies were 
DCCT aligned, the ORCADES values were adjusted to the DCCT scale using the 
following conversion factor:  
DCCT HbA1C = (IFCC HbA1C * 0.9148) + 2.152  
 
Individuals with type 1 diabetes are always treated with insulin injections. T2D 
patients are usually treated initially non-pharmacologically through dietary advice. If 
however, dietary changes fail to control the individual’s hyperglycaemia then oral 
glucose lowering drugs will be prescribed and in a small proportion of T2D cases 
insulin injections may become necessary. 
 
Pharmacological interventions will results in altered levels of the glycaemic traits to 
those that would be predicted from their genetic and other environmental factors. In 
this case we are attempting to identify and quantify the genetic factors so not 
controlling for the medication effects may confound our ability to detect the genes in 
question. 
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There are several commonly used methods to control for medication effects in 
quantitative trait analysis as described in the section 2.6. In the case of diabetes the 
proportion of medicated individuals in our studies was between 2.1% and 9.2% and 
ultimately the simplest method was to exclude from the main analysis anyone who 
was taking oral medication or insulin injections. 
 
Descriptive statistics for all the glycaemic phenotypes and relevant covariates are 
shown in table 5. The distribution of measured traits and covariates varied 
considerably between populations. All studies had a higher proportion of females 
than males. The MICROS population had the lowest mean age of 45 years and the 
VIS population was oldest with a mean age of 55 years. Mean BMI ranged from 25.6 
kg/m2 in MICROS to 27.9 kg/m2 in KORČULA. The usage of diabetic medications 
and hyperglycaemia was highest in the two Croatian island populations with over 9% 
of the VIS study sample taking some form of glucose lowering medication. The 
ORCADES population had the lowest levels of glucose lowering medication with 
only 2.1%. The prevalence of diagnosed diabetes in Scotland overall is estimated to 
be 3.9%(McKnight, Morris et al. 2008).  
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Table 5. Descriptive statistics for the 5 Genome Wide Association studies. 
  ERF Orkney Tyrol Vis KORČULA  
N 918 719 1097 795 888 
%Female 61.4 53.5 56.7 58.7 63.9 
Age (years) 53.5 (15.2) 53.6 (15.7) 45.3 (16.1) 56.6 (15.4) 56.2 (13.9) 
BMI (kg/m2) 26.9 (4.7) 27.8 (4.9) 25.6 (4.83) 27.3 (4.25) 27.9 (4.15) 
Fasting Glucose 
(mmol/l) 4.7 (1.1) 5.4 (0.98) 4.7 (1.08) 5.7 (1.49) 5.8 (1.55) 
Insulin (mU/l) 12.6 (6.7) 6.7 (4.9) na 9.4 (19.4) na 
HOMA-IR 2.6 (1.76) 1.5 (1.09) na 2.4 (7.06) na 
HOMA-B 640 (4069) 71 (40) na 88 (342) na 
HbA1C  (%) na 3.7 (0.8) na 5.5 (0.9) 5.8 (0.8) 
Diabetes 
Medication(%) 4.9 2.1 3.6 9.2 6.3 
 
4.4.1 FG – ORCADES, Vis, KORČULA, ERF, MICROS 
FG measurements are the most widely used diagnostic test for T2D. Levels over 7 
mmol/l on more than one occasion suggest a serious breakdown in glucose 
homeostasis and are used to diagnose diabetes.  
 
A more accurate measure of glucose response can be obtained by an Oral Glucose 
Tolerance Test (OGTT) which tracks an individual’s plasma glucose levels for 2hrs 
after a glucose challenge. Although desirable for the greater amount of information 
obtained this test is more time consuming than a single blood test. It also involves 
either multiple venepunctures or cannulation. 




As a commonly used diagnostic test, and because of the relative ease of 
measurement, FG is the more widely studied in a genetic context than the other T2D 
related phenotypes. In recent years many independent genome-wide association 
studies have been conducted on FG levels and large-scale meta-analyses of these 
studies have been performed(Prokopenko, Langenberg et al. 2009; Dupuis, 
Langenberg et al. 2010). These meta-analyses have provided a number of well-
replicated associations, which are now the subject of more detailed molecular study. 
 
The results from our own meta-analysis are interesting both in the context of 
replicating well known associations, which can be considered positive controls for 
the quality of our study, and by providing novel associations not identified in the 
larger meta-analysis studies. 
 
The first instinct when observing an association in a study of 4000 individuals, which 
does not appear in a larger analysis totaling over 100,000 samples, would be that the 
result is a false positive appearing by chance in our data and this may indeed be the 
case. However, the studies used here were all collected from genetically isolated 
populations in the hopes that allele frequency changes within these populations may 
allow detection of variants that are rarer in the larger European population. They 
could also potentially have a reduced number of genetic influences some of which 
may have been lost due to genetic drift(Sheffield, Stone et al. 1998). Coupled with 
the arguably more uniform environment found within these small populations this 
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should lead to stronger relative effect sizes for the polymorphisms which do still 
exist(Shifman and Darvasi 2001; Heutink and Oostra 2002). 
 
For these reasons two sets of results from our meta-analysis association scans are of 
interest. Firstly, the highest scoring association results overall, and secondly the 
association results obtained for well-known, replicated FG polymorphisms. As might 
be expected in some cases these two lists will overlap. 
 
Figure 17. GWAS meta-analysis results for FG in 5 populations with age sex and BMI as 
covariates
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Figure 18. QQ plot of Fasting Glucose meta-analysis results 
 
Table 6 shows the highest scoring associations for FG using a model including age, 
sex and BMI as covariates. The cut-off point for the table was a p-value less than 
1x10-5. The strongest evidence for association is with SNP rs560887 on chromosome 
2. A further five of the ten most highly associated SNPs are in the same 
chromosomal region. This region contains the gene Glucose-6-phosphatase 2 
(G6PC2) for which association has been previously reported with both FG and 
HbA1C (Chen, Erdos et al. 2008; Pare, Chasman et al. 2008). Two of the six 
associated markers also show strong evidence for association in the female-only 
analysis but not the male specific analysis. This could represent a genuine 
differential sex effect for these polymorphisms, but alternatively could reflect 
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differences in power arising from the gender skew present in the study populations, 
which results in considerably larger numbers for the female specific analyses. 
 
The marker rs13078632 on chromosome 3 also shows association with FG 
(p=9.48x10-6). This marker is located in the 3-prime un-translated region of the 
Kelch Repeat and BTB domain-containing protein 8 (KBTBD8), which is involved in 
T-cell activation. 
 
Two markers on chromosome 11 show association. One of these markers, 
rs1387153, has previously been identified in large-scale analysis of FG and T2D. 
This variant is located near the Melatonin Receptor 1B (MTNR1B). The other 
chromosome 11 association (rs17372123) falls within the gene encoding 
Haemoglobin subunit gamma-2 (HBG2). The last association found in analysis of all 
individuals is rs2907666 that lies approximately 150 kb upstream of a cluster of 
genes including TOM1L1, COX11 and STXBP4, none of which have an obvious role 
in glycaemic control. 
 
The sex-specific analysis was performed using age and BMI as covariates. There is 
some overlap between genes that show up in the overall analysis and those that are 
most significant in the sex-specific analysis but there are also some markers that 
show association only in one gender. This could represent a genetic effect that is 
mediated in someway by transcriptional or hormonal differences between the 
genders. It must also be considered that with the reduced sample sizes for the sex 
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specific analysis power to detect true associations is reduced and the chance of false 
positive results increases. 
 
In addition to the associations with MTNR1B and G6PC2 already found in the non-
stratified analysis the female-only meta-analysis shows associations on chromosome 
3 with the Glutamate Receptor 7 (GRM) and a separate signal within an intron of the 
Chemokine XC Receptor (XCR1). There are also associations on chromosome 16 
with Ataxin-2-binding Protein (A2BP1) and on chromosome 22 with a particularly 
gene-rich region containing several uncharacterized protein-coding genes. 
 
The analysis of only the male subjects yielded just one association with a p-value 
less than 1 x 10-5 on chromosome 8. This marker does not fall within any gene but is 
downstream of several genes involved in signal trafficking. 
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Table 6. Top association results for fasting glucose in 5-population meta-analysis. 
Gene SNP Allele Freq Chr Position (mb) N Effect S.E. p-value 
G6PC2 rs3931 G 0.28 2 169.5 3940 -0.08 0.02 2.16x10-6 
G6PC2 rs560887 G 0.71 2 169.6 3975 0.08 0.02 5.36x10-7 
G6PC2 rs563694 C 0.36 2 169.6 3966 -0.06 0.01 5.64x10-6 
G6PC2 rs503931 C 0.52 2 169.6 3972 0.05 0.01 7.00x10-6 
G6PC2 rs2685814 G 0.53 2 169.6 3952 0.05 0.01 3.18x10-6 
G6PC2 rs853778 G 0.52 2 169.6 3975 0.06 0.01 1.99x10-6 
KBTBD8 rs13078632 G 0.14 3 67.1 3972 -0.12 0.03 9.48x10-6 
MTNR1B rs17372123 C 0.33 11 5.5 3961 0.07 0.02 9.72x10-6 
HBG2 rs1387153 G 0.73 11 92.3 3974 -0.08 0.02 9.65x10-6 
TOM1L1 rs2907666 G 0.83 17 50.2 3967 -0.11 0.02 2.98x10-6 
 
 
Other large-scale analyses have identified a large catalogue of FG loci during the 
period of this phd project. Examining the most highly significant SNP markers from 
these studies I identified 16 loci for which we had genotyped the reported marker 
itself or nearby proxy SNPs in strong LD. The meta-analysis results for these 16 loci 
are shown in table 7. As previously mentioned, association with the MTNR1B and 
G6PC2 genes showed strongly in our data. There were also weaker association 
signals with the Glucokinase gene (GCK) and its receptor (GCKR). Although these 
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genes have previously recognized, and entirely logical, roles in FG control they 
would not have been identified in this analysis of nearly 4000 individuals. 
Table 7. 5-population meta-analysis association results for previously identified fasting glucose 
markers. 
Gene Proxy Distance R2 Allele Freq N Effect S.E. p-value 
ADCY5 rs2877716 28673 0.82 G 0.76 3972 0.03 0.02 0.16 
ADRA2A rs10787315 9367 0.82 G 0.92 3945 0.10 0.04 4.53x10-3 
C2CD4B rs12440695 1194 1.00 G 0.37 3975 -0.01 0.01 0.69 
DGKB-
TMEM195 rs2191348 54 1.00 C 0.45 3969 -0.03 0.01 0.03 
DGKB-
TMEM195 rs10244051 476 1.00 C 0.55 3976 0.02 0.01 0.04 
FADS1 rs174546 1648 1.00 G 0.67 3976 0.02 0.02 0.20 
FADS1 rs174556 9157 0.80 G 0.72 3975 0.01 0.02 0.45 
FADS1 rs102275 13675 1.00 G 0.34 3975 -0.02 0.02 0.13 
FADS1 rs174537 18798 1.00 C 0.68 3949 0.02 0.02 0.15 
FADS1 rs1535 26494 1.00 G 0.33 3974 -0.02 0.02 0.12 
G6PC2 rs560887 0 1.00 G 0.71 3975 0.08 0.02 5.36x10-7 
G6PC2 rs563694 0 1.00 C 0.36 3966 -0.06 0.01 5.64x10-7 
GCK rs4607517 0 1.00 G 0.81 3967 -0.07 0.02 7.76x10-4 
GCKR rs780094 0 1.00 G 0.61 3969 0.03 0.01 0.04 
GCKR rs1260333 7387 0.87 G 0.55 2185 0.01 0.02 0.51 
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GCKR rs1260326 10297 0.93 G 0.59 3245 0.03 0.01 0.07 
GLIS3 rs7041847 1584 0.94 G 0.48 3975 0.00 0.01 0.81 
GLIS3 rs10814916 4100 0.81 C 0.53 3974 0.00 0.01 0.79 
MADD rs11039149 59645 1.00 G 0.31 3972 -0.04 0.02 0.03 
MTNR1B rs1387153 0 1.00 G 0.73 3974 -0.08 0.02 9.65x10-6 
PROX1 rs340874 0 1.00 G 0.53 3973 0.02 0.01 0.11 
SLC2A2 rs5400 14779 1.00 G 0.87 3957 0.08 0.03 2.69x10-3 
SLC2A2 rs11919048 143356 0.87 G 0.86 3972 0.05 0.03 0.09 
SLC30A8 rs13266634 950 0.96 G 0.71 3972 0.03 0.02 0.06 
TCF7L2 rs7901695 1953 0.88 G 0.31 3241 0.05 0.02 5.29x10-3 
TCF7L2 rs7903146 2308 0.92 G 0.71 3975 -0.05 0.02 1.13x10-3 
ZMAT4 rs2722425 0 1.00 G 0.89 3976 -0.03 0.03 0.38 
 
 
4.4.2 FI – ORCADES, VIS, ERF 
The FI analysis was conducted in a similar way to the FG analysis. Individuals 
taking diabetic medications were excluded, the highly skewed trait was rank-
transformed to normality, variance attributable to polygenic effects was corrected for 
and association analysis was performed for each study population using the FASTA 
test.  
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In the meta-analysis, shown in figure 19, no individual SNP reached a genome-wide 
significant level of association and it can be seen from the QQ plot (figure 20) that 
the distribution of results showed no inflation when compared to the null. 
 
Figure 19. GWAS meta-analysis results for FI levels in ORCADES, VIS and ERF populations 
with age sex and BMI as covariates 
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Figure 20. QQ plot of Fasting Insulin meta-analysis results 
 
 
The strongest association result seen for FI is with SNP rs1936002 (table 8), which 
falls within an intron of the serine/threonine-protein kinase DCLK1. The other FI 
association found in the analysis of all individuals is rs3785690, which resides within 
an intron of the Heparan Sulfate Glucosamine 3-O-sulfotransferase 3A1 
(HS3ST3A1).  
 
In the sex-specific analysis of males no marker showed evidence for association 
beyond the p < 1x10-5 threshold. In the female-only analysis there were 3 associated 
markers, one in the TBC1 domain family member 5 gene (TBC1D5) on chromosome 
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3, one downstream of the coiled-coil domain containing protein 60 (CCDC60) on 
chromosome 12 and one on chromosome 18 downstream of the ROCK1 (Rho-
associated, Coiled-coil containing protein kinase 1) gene which doesn’t have any 
obvious role in insulin control. 
 
Association results for previously reported FI SNPs and/or their closest available 
proxies are shown in table 9. My analysis shows nominal evidence of association at 
the Insulin Growth Factor (IGF1) locus but no evidence in support of the GCKR 
locus. 
 
Table 8. FI meta-analysis association results 
Gene 
SNP Allele Freq Chr 
Position 
(mb) N Effect S.E. p-value 
DCLK1 rs1936002 G 0.54 13 35.4 2115 0.15 0.03 6.38x10-6 
HS3ST3A1 rs3785690 G 0.84 17 13.4 2115 0.20 0.04 6.18x10-6 
 
Table 9. Meta-analysis results for previously reported FI loci. R2 correlation 
with previously reported SNP based on HapMap CEU data. 
Locus Chr SNP Position (mb) R2 P-value 
IGF1 12 rs2162679 101.4 0.92 0.006 
IGF1 12 rs35766 101.4 0.92 0.009 
GCKR 2 rs1260326 27.6 0.93 0.75 
GCKR 2 rs1260333 27.7 0.87 0.49 
GCKR 2 rs780094 27.6 1 0.82 
 




4.4.3 HOMA-IR/B - ORCADES, VIS, ERF 
HOMA-IR, calculated as a product of FI and FG levels, and HOMA-B, calculated as 
a ratio of FI to FG, were examined in the populations that had obtained both of these 
phenotypes. Both phenotypes have a strong skew and were transformed by natural 
logarithm prior to analysis. 
 
The strongest association with HOMA-IR is the SNP rs3790451 (table 10), which 
lies within the Ecotropic Viral Integration site 5 (EVI5). There are several other 
protein coding genes within a few hundred kilobases of this site but none with well-
explored functions. 
 
The female-specific analysis of HOMA-IR showed 4 markers beyond the p<1 x 10-5 
threshold level. There are two associations on chromosome 8 separated by 7 Mb. The 
first falls within a ribosomal gene RPS15A and the second is in the Hepatocyte 
Nuclear Factor 4-gamma (HNF4G) gene.  
 
Two of the top 3 associations with HOMA-IR in the male-specific analysis cluster 
together on chromosome 1 in a gene-poor region. The other association found in the 
analysis is more promising, lying within the Insulin-like Growth Factor 1A precursor 
(IGF1A). 






Figure 22. QQ plot of HOMA-IR meta-analysis results 
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Figure 23. GWAS meta-analysis results for HOMA-B in ORCADES, VIS and ERF populations 
with age sex and BMI as covariates 
 
Figure 24. QQ plot of HOMA-B meta-analysis results 
 




Table 10. HOMA-IR meta-analysis association results for ORCADES, VIS and 
ERF populations 
Gene SNP Allele Freq Chr Position (mb) N Effect S.E. p-value 
EVI5 rs3790451 G 0.48 1 92.9 2093 -0.15 0.03 2.88x10-6 
 
The results obtained from HOMA-B analysis (table 11) showed an association on 
chromosome 8 with rs10504962 (p=1.8 x 10-6) upstream of the Syndecan (SDC2) 
locus. The second strongest association, rs2871491 (p=4.1 x 10-6), falls within the 
SORB2 gene. 
 
Table 11. HOMA-B meta-analysis association results for ORCADES, VIS and 
ERF populations 
Gene SNP Allele Freq Chr Position (mb) N Effect S.E. p-value 
SORB2 rs2871491 G 0.82 4 186.9 2102 -0.2 0.04 4.12x10-6 
None rs11132593 G 0.52 4 190.1 2096 -0.14 0.03 8.63x10-6 
SDC2 rs10504962 G 0.9 8 97.5 2083 0.26 0.05 1.79x10-6 
ETNK1 rs11046815 G 0.6 12 23.2 2101 0.15 0.03 9.05x10-6 
 




4.4.4 HbA1C   ORCADES, VIS, KORČULA  
The association analysis of HbA1C levels showed 3 hits above the Bonferroni 
correction threshold (figure 25). The two strongest association signals were with 
markers rs7903146 (p = 1.48 x 10-7) and rs12255372 (p = 8.44 x 10-7) in the TCF7L2 
locus (table 12). This result was of particular interest because, while these SNPs have 
previously been shown to associate strongly with T2D (Grant, Thorleifsson et al. 
2006), they had not previously been shown to affect HbA1C levels within the healthy 
non-diabetic population. The results of this analysis were published during the 
writing of this thesis and are attached in appendix A (Franklin, Aulchenko et al. 
2010). 
 
The association results from the individual studies are shown for rs7903146 in table 
13. Effect estimates in this case are calculated based on untransformed HbA1C levels 
and are therefore expressible in units of % HbA1C. While the SNP does not approach 
genome-wide significance in any of the studies, it does show a consistent size and 
direction of effect. 
 
The third most significant SNP (rs12366899, p=1.14x10-6) was only genotyped in the 
KORČULA study and, based on the very small number of samples is likely to be a 
false positive artifact. 
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Figure 25. GWAS meta-analysis results for HbA1C in ORCADES, VIS and KORČULA 
populations with age sex and BMI as covariates 
 
Figure 26. QQ plot of HbA1C meta-analysis results 
 
Linkage and Association Mapping for Quantitative Phenotypes in Isolated Populations 
 
 98 
Table 12. HbA1C meta-analysis association results for ORCADES, VIS and 
KORČULA populations 
Gene 
SNP Allele Frequency Chr 
Position 
(mb) N Effect S.E p-value 
TCF7L2 rs7903146 G 0.72 10 114.7 1782 -0.20 0.04 1.48x10-7 
TCF7L2 rs12255372 C 0.73 10 114.8 1782 -0.19 0.04 8.44x10-7 
None rs12366899 G 0.64 12 125.6 406 0.42 0.09 1.14x10-6 
 
Table 13. Association results for rs7903146 in individual populations.  
(Statistics are reported for the G allele. Effect estimates and standard errors are 
calculated using untransformed HbA1C values. P-values are calculated using rank 
transformed data.) 
Population N Freq Effect (%HbA1C) S.E. P-Value 
Meta-Analysis 1782 0.72 -0.054 0.014 1.48 x 10-7 
ORCADES 664 0.74 -0.067 0.024 1.41 x 10-4 
VIS 707 0.71 -0.044 0.021 1.54 x 10-2 
KORČULA 411 0.71 -0.056 0.033 4.21 x 10-3 
 
4.5 Discussion 
The analysis shown here demonstrates the benefits of meta-analysis. The individual 
studies had quite small sample sizes and were greatly underpowered to detect QTs 
with the very small effect sizes that we now know to expect. As a result the highest 
associations obtained from individual studies are quite likely to be false positives. 
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However, by pooling up to 5 of these small studies we were able to improve the 
power for detection and bring associations, which we know from larger concurrent 
studies to be genuine, to the top of our results tables. 
 
Two of the most widely replicated FG genes, G6PC2 (p=5.36x10-7) and MTNR1B 
(p=9.65x10-6), showed strong association in our meta-analysis and, in the absence of 
other research in the area, our own study would have identified and sought 
replication for these loci. Several more known loci showed nominally significant 
associations including ADRA2A (p=4.53x10-3), DGKB-TMEM195 (p=0.03), GCK 
(p=7.76x10-4), GCKR (p=0.04), MADD (p=0.03), SLC2A2 (p=2.69x10-3) and 
TCF7L2 (p=5.29x10-3). While these loci may not have been taken forward for 
replication based on our own results they do still represent a form of positive control. 
 
 Perhaps the more interesting results are the known and well-replicated loci that do 
not show any evidence of association in our data. The ADCY5, C2CD4B, FADS1, 
GLIS3, PROX1, SLC30A8 and ZMAT loci have all shown strong evidence for 
association in published FG GWAS analyses and yet the same reported SNP 
markers, or nearby proxy SNPs present in our data, do not show even nominal 
significance in our meta-analysis of 4,000 individuals.  
 
This lack of replicating could indicate the limitations of our study. Even after the 
pooling of 5 studies our meta-analysis still has considerably lower power to detect, at 
genome-wide significance levels, variants with very small effect sizes than the very 
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large meta-analyses in which many of these loci were identified. However, even with 
a smaller sample our study should have substantial power to detect these variants at a 
nominal p<0.05 threshold.  
 
Some alternate explanations would be that the nature of our isolated population study 
design results in different environmental modifiers than are found in cosmopolitan 
populations, and it is possible that some genetic variants will only have an effect on 
the phenotype in the presence of such modifiers. 
 
In order to be confident of identifying QTs with small effect sizes, extremely large 
sample sizes are required. To this end we have joined a number of international 
consortia, which have been, and continue to conduct, very large meta-analyses of the 
traits discussed here. Depending on how commonly measured the traits are these 
analyses now consist of 40 to over 100 thousand samples, allowing the detection of 
variants with effect sizes as small as 0.25% of phenotypic variation in some cases. 
 
The value in identifying genetic variants with such small individual effect sizes is 
somewhat different to the outcome of studying monogenic disorders. While each 
new discovery of this magnitude may not be revolutionary alone they do add to 
knowledge of the mechanisms of disease development and may lead to the 
investigation of pathways that may not otherwise have been explored. 
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Results obtained from association studies can be roughly divided into 3 groups:  
1. Association with a gene or pathway that has a plausible role in studied trait or 
disease based on previously determined function.  
2. Association with a gene or pathway, which does not have an obvious connection 
to the trait or disease being studied. 
3. Association that falls far from any coding gene. 
 
4.5.1 Genes with known function 
The way in which some of the known glucose genes may be influencing glucose 
concentrations and related traits is quite straightforward. The GCK gene, for 
example, produces a type of hexokinase which is expressed primarily in the liver and 
which catalyses the first step in glucose metabolism (glycolysis). The enzyme 
activity of GCK is proportional to glucose concentration, increasing as glucose levels 
rise after a meal and bottoming out when the glucose levels are reduced to a normal 
level(Gloyn 2003). This function makes GCK potentially the most obvious candidate 
for association with fasting glucose levels. 
 
Secondly the primary function of the GCKR protein is to regulate the activity of the 
GCK enzyme. It does this by binding the GCK in the cellular cytoplasm, preventing 
the binding of glucose and inactivating the enzyme. The GCKR then travels to the 
nucleus, reducing cellular GCK concentration. Rising cellular glucose concentration 
inhibits GCKR function therefore releasing GCK to perform it function(Beer, 
Tribble et al. 2009). Alterations to the function of GCKR which caused the protein to 
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become insensitive to glucose concentrations or which caused tighter binding of the 
GCK enzyme could easily result in hyperglycaemia and ultimately in the 
development of T2D. 
 
The G6PC2 enzyme is primarily active in pancreatic cells. Whereas GCK is involved 
in the metabolism and storage of glucose and becomes active in higher than optimal 
glucose conditions, the G6PC2 enzyme is involved in the gluconeogenic and 
glycogenolytic pathways, which release stored glucose when blood glucose levels 
are too low(Hutton and O'Brien 2009). Again it is easy to see how a mutation which 
altered the normal regulation of this protein or which caused over expression of the 
coding gene could result in increased FG and over time cause a breakdown of 
glucose homeostasis leading to the development of T2D. 
 
4.5.2 Genes with unknown function 
MTNR1B is an excellent example of a gene which may not have been expected to 
show strong association with FG and may not have been chosen in candidate gene 
studies, prior to the large-scale GWAS analysis that first identified the link 
(Prokopenko, Langenberg et al. 2009). The investigators who identified the gene 
were however able to provide supporting biological evidence for the role, 
highlighting the known expression patterns of the MTNR1B gene, which demonstrate 
substantial expression in pancreatic islets (Ramracheya, Muller et al. 2008). This 
expression localization, coupled with evidence that melatonin inhibits the release of 
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insulin (Stumpf, Muhlbauer et al. 2008), demonstrates a reasonable explanation for 
the role of the melatonin receptor in regulation of blood glucose levels. 
 
4.5.3 Associations in gene deserts 
In some cases a statistically significant association may fall within a region that 
contains no known or predicted gene sequences. At first consideration this may seem 
less interesting. However as we are dealing with QTLs, which exert a small level of 
control over a continuous trait, it is important to consider regulatory elements that 
modify levels of gene expression. These can be positioned a great distance from the 
actual coding sequence which they act on(Hakim, John et al. 2009). 
 
Many different methods have been attempted to identify promoter regions and 
regulatory elements from genome sequences. For example CpG islands can be 
searched for, this being a region in which a higher proportion of CG di-nucleotide 
pairs exist. This usually denotes a region that is actively transcribed(Fatemi, Pao et 
al. 2005). 
 
An alternative method is comparison of sequences from related species to identify 
regions which are conserved across, for example higher primates or all mammalian 
species. A higher degree of sequence conservation suggests a region is important 
functionally(Hardison 2000), although rapidly evolving regions may of course also 
have important species-specific roles(Hardison, Krane et al. 1991). 
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4.5.4 Glycaemic phenotypes and T2D 
As mentioned the study of continuously distributed glycaemic phenotypes within a 
normal healthy range is complementary to the to the study of T2D as a binary disease 
state and as such we would hope to identify loci in our scans of FG and other traits 
which also convey risk for developing T2D. Given the modest sample sizes of our 
studies and the low population prevalence of T2D we do not have enough disease 
cases in our own sample data to draw conclusions about this. However it has been 
shown by larger meta-analyses, to which we contributed data, that many loci initially 
identified in analysis of FG are also strongly associated with T2D risk(Dupuis, 
Langenberg et al. 2010).  
 
In the Dupuis analysis of 40,655 T2D cases and 87,022 controls 7 out of 17 loci 
which had been shown to have genome-wide significant associations with glycaemic 
phenotypes were also significantly associated with T2D as a binary disease trait. 
They also demonstrated that 11 out of 18 known T2D loci had at least nominally 
significant and directionally consistent association with FG(Dupuis, Langenberg et 
al. 2010). 
 
Of particular note from the Dupuis analysis; the MTNR1B locus, which was strongly 
associated with FG in my own meta-analysis, had a significant risk for T2D with a 
relative risk of 1.09 for the FG raising allele. By contrast the most strongly 
associated FG signal in my analysis G6PC2 gives a very weak and directionally 
inconsistent risk for T2D in the Dupuis analysis (RR=0.97, P=0.012). Dupuis noted 
that “a large T2D effect size does not always translate to an equivalently large FG 
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effect in non-diabetic persons”(Dupuis, Langenberg et al. 2010). This highlights the 
value of studying both case-control disease states and quantitative phenotypes.  
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5 Chapter 5: Genome-wide association of Pulse Wave 
traits in 2 isolated populations 
5.1 Background to pulse wave analysis relating to 
cardiovascular disease. 
As previously discussed CVD causes the largest proportion of deaths in the 
developed world and is estimated to be responsible for over 17 million deaths per 
year worldwide(WHO 2008). 
 
Hypertension is a common condition estimated to affect approximately 26.4% of the 
adult population of the world(Kearney, Whelton et al. 2005). It is also known to be 
the strongest predictor of CVD development and outcome(He and Whelton 1997). 
Case control GWAS studies of hypertension and quantitative trait GWAS studies 
using systolic (SBP) and diastolic (DBP) blood pressure measures have been 
conducted in an attempt to identify genetic risk loci that influence control of BP and 
may play a role in the development of CVD (Cho, Go et al. 2009; Levy, Ehret et al. 
2009; Newton-Cheh, Johnson et al. 2009; Org, Eyheramendy et al. 2009; Wang, 
O'Connell et al. 2009).  
 
Results obtained in early GWAS studies had considerably less success in identifying 
loci for hypertension when compared to studies of other complex disorders of 
comparable size (WTCCC 2007) and similarly, studies using BP as a continuous 
outcome, which would be expected to have greater power than studies using a 
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categorical outcome measure, have required extremely large sample sizes to identify 
reliable association signals(Levy, Ehret et al. 2009). This may be due in part to the 
relatively poor reproducibility of BP measures when compared to, for example, 
blood biochemistry measurements(Crilly, Coch et al. 2007). 
 
In addition to variation arising from measurement error BP is also susceptible to 
environmental influences that result in biological variability. It has been shown that 
factors such as recent smoking, needing to urinate or even verbal interaction during 
measurement result in substantial increases in BP measurements. Even in the most 
controlled environment some people react nervously to the clinical setting in which 
most BP measurements are taken creating a variable inter-individual “white coat 
effect” such that BP measurements from these settings do not reflect usual 
BP(Handler 2009). These additional sources of variance may obfuscate the 
relationships between long-term genetic influences on CVD and the snapshot 
measurement of BP.  
 
It is also important to note that traditional measures of SBP and DBP give only an 
estimate of pressure in the peripheral arteries, SBP being a measure of the peak 
arterial pressure and DBP being a measure of the minimum peripheral pressure as the 
ventricles relax and the heart fills with blood. These peripheral pressure 
measurements may not accurately reflect the central arterial pressure particularly in 
the presence of decreased arterial elasticity (O'Rourke 1990; Papaioannou, 
Protogerou et al. 2009). When attempting to monitor or predict CVD risk, central 
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pressure is a stronger risk factor than peripheral BP and so an accurate estimate of 
central pressure should provide a better phenotype for identifying CVD risk genes. 
 
One of the major causes of arterial stiffening is the formation of atheromatous 
plaques (atherosclerosis), which results in part from elevated levels of circulating 
LDL-cholesterol collecting in arterial lesions. As a major risk factor in CVD 
measures of blood lipid levels have been used extensively in GWAS analysis(Tohidi, 
Hatami et al. 2010). 
 
More complex analysis of BP could theoretically prove more successful in 
identifying CVD risk genes by separating the observed variation into the individual 
components of cardiac function, valvular function and arterial function(Papaioannou, 
Protogerou et al. 2009).  
 
The two leading, non-invasive methods for measuring arterial stiffness are Pulse 
Wave Velocity (PWV) and Pulse Wave Analysis (PWA). PWV is calculated by 
detecting the arterial pulse wave at two points, for example at the carotid and femoral 
arteries. Taking the known distance between the two measurement points and 
dividing this by the measured time interval between the peak pressures at these two 
points gives the velocity of the pulse wave(Blacher, Asmar et al. 1999). 
 
The PWA method uses a single measurement point at the radial artery(Papaioannou, 
Protogerou et al. 2009). A highly sensitive tonometry device is applied and measures 
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the changes in radial pulse pressure. The classical shape of the waveform, as shown 
in figure 27, is formed by the outgoing pulse wave and a weaker reflected wave as 
pressure in the peripheral arteries maximizes and the direction of flow reverses. The 
classical SBP and DBP measures represent the maximum and minimum of the 
waveform and in a healthy individual with extremely well functioning arteries these 
values should be proportional to the central arterial pressures. However, when there 
is significant arterial stiffness, the speed of the wave increases which in turn reduces 
the time until the reflected wave and thus increases the overlap between outgoing 
and reflected waves generating an augmentation of the peak pressure 
measurement(O'Rourke, Pauca et al. 2001). 
 
The pressure waveform can be broken down into two time periods. The first is the 
systolic period, beginning when the left ventricle contracts and the aortic valve opens 
and ending when the aortic valve closes causing a small increase in arterial pressure 
known as the dicrotic notch(O'Rourke, Pauca et al. 2001). The diastolic period, 
during which the heart relaxes and fills with blood causing the arterial pressure to 
reduce, then lasts until the next pulse cycle. 




Figure 27. Example pulse waveform describing key elements 
 
 
There are several key elements of the pulse waveform from which our phenotypic 
data were derived. Firstly deriving the maximum slope at the start of the systolic 
pressure wave (MaxDp/dt) gives the maximum rate of pressure change during each 
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pulse and so can indicate problems with the functioning of the aortic valve(Starr, 
Ambrosi et al. 1973). 
 
The ejection duration (EDA) is a measure of the systolic time period. At the end of 
the ejection period when the aortic valve closes and the dicrotic notch is observed the 
pressures within the left ventricle and arteries are approximately equal and so this 
ejection systolic pressure (ESP) gives an estimate of the ventricular pressure at the 
end of systole. 
 
There are two peak pressure measurements P1 and P2 at time points T1 and T2 
respectively. P1 is the peak of the outgoing pressure wave caused by ventricular 
contraction. P2 is the peak of the reflected wave. In a healthy individual P1 will be 
greater than P2 as the reflected wave will not occur until after the peak of the systolic 
pressure wave. However, when arterial stiffness results in an earlier stronger 
reflected wave the overlap will result in P2 becoming the maximum pressure 
measurement. A simplified measure of SBP cannot distinguish between these two 
cases. The pulse pressure PP is the difference between the maximum pressure 
measured during the pulse cycle, either P1 or P2, and the minimum diastolic 
measurement.  
 
The interval between T1 and T2 (ΔT) estimates the time between the outgoing wave 
and the reflected wave and is proportional to the velocity of the pulse wave. This 
period will become shorter as the arteries become less flexible and BP rises. 
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The augmentation pressure (AP) is the difference between P1 and P2 representing a 
measure of the inflation of systolic pressure due to arterial stiffness. In healthy 
individuals the reflected wave should be delayed sufficiently that P2 is smaller than 
P1 and the AP is negative but in hypertensive individuals the rapidly and strongly 
reflected wave causes a substantial increase in pressure resulting in large positive 
values of AP. The clinical impact of this augmentation is relative to the overall 
pressure and so a commonly used alternative variable is the augmentation index 
(AIx), which is the AP expressed as a proportion of the PP. The AIx phenotype can 
be further refined by correcting for the differences resulting from heart rate (HR) and 
standardising to a HR of 75 beats per minute (AIx75). 
 
Integration across the entire pulse waveform can give a measure of the overall mean 
arterial pressure (MeanP) indicating the general load on arterial tissues, while 
decomposition of the curve into the systolic and diastolic components to obtain a 
ratio gives the systolic ventricular index (SVI) also known as the Buckberg index. 
 
Measuring theses phenotypes at the radial artery gives an estimation of peripheral 
arterial function, however the SphygmoCor PWA method allows for derivation of 
the central aortic waveform from which the same features can be calculated. The 
derivation of the central aortic waveform uses a general transfer function based on 
the experimentally defined relationship between radial and aortic pressures. The 
transfer function was originally calculated using simultaneous direct measurement of 
central aortic pressure and radial pressure in 20 patients undergoing cardiac 
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catheterisation surgery (Chen, Nevo et al. 1997). The general transfer function 
estimated from this study and implemented by the SphygmoCor system has been 
determined to be accurate by a subsequent replication study in which 62 
cardiopulmonary bypass patients were assessed for directly measured aortic pulse 
waves and simultaneous derived central waveforms from radial tonometry (Pauca, 
O'Rourke et al. 2001). 
 
The ability to derive central pressure waveforms is extremely important in relation to 
estimating CVD risk as the central pressure have been shown to be give far better 
prediction of cardiovascular disease outcomes than peripheral pressure 
measurements (Papaioannou, Protogerou et al. 2009).  
 
To date only one genome-wide association (GWA) study has been performed using 
PWA phenotypes obtained using applanation tonometry. The Framingham heart 
study used 644 individuals and approximately 71,000 SNP markers tested against a 
battery of PWA ascertained from radial, brachial and femoral artery tonometry 
(Levy, Larson et al. 2007). The study identified several possible candidate regions, 
which showed weak association with one, or more of their tonometry phenotypes but 
none of the associations reached genome-wide significance or has yet been 
independently replicated. 
 
Other studies of the genetics of arterial stiffness have focused on individual or small 
panels of candidate genes for which there is a biological link to arterial structure or 
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which have been previously implicated in cardiovascular disease studies. These 
studies have demonstrated association between a number of genes and one or more 
arterial stiffness phenotypes.  
 
The genes encoding angiotensin (AGT), the angiotensin-converting enzyme (ACE), 
which converts angiotensin I to the more active angiotensin II, and the angiotensin 
receptor (AGTR1) have all shown association with arterial stiffness phenotypes, 
predominantly focusing on PWV, in candidate gene studies. This pathway has a 
known function in compensation for hypotension and polymorphisms in its 
component genes have been shown to interfere with the treatment of hypertension 
(Chung, Deng et al. 2009; Konoshita, Kato et al. 2009). 
 
Other arterial stiffness studies have focused on structural elements with roles in 
cardiac tissue development. Some positive evidence for association has been found 
including elastin (Hanon, Luong et al. 2001), collagen (Brull, Murray et al. 2001)and 
fibrillin (Medley, Cole et al. 2002) genes.  
 
While many of these candidate studies produced positive results, the evidence for 
association is relatively weak when compared to the levels required in a GWAS 
study and there are also a great many contradictory candidate gene publications 
showing no association with the same genes and phenotypes. For a full review see 
(Yasmin and O'Shaughnessy 2008). 
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We have used PWA to estimate the degree of arterial stiffness in healthy individuals 
from the ORCADES and KORČULA populations. The benefit of conducting 
genome-wide association is that no prior assumptions need to be made about the 
mechanisms underlying the disease and no prior knowledge of the function of the 
genes in question is needed. This allows for the identification of novel and 
unexpected candidates. 
 
Our study has several benefits over the previous GWA study. Firstly we have 
performed meta-analysis of two distinct European populations. This provides internal 
replication of results, decreasing the chance of identifying false positives. Secondly 
we have genotyped over 300,000 single nucleotide polymorphisms (SNPs), 
providing considerably greater coverage of the genome. We have also conducted 
replication of a small number of the most significantly associated SNPs in a third 
independent cohort comprising 3,000 healthy British individuals.  
 
Description of data collection 
Pulse wave data were captured as part of a battery of tests in both study populations, 
for which participants had fasted for at least 2 hours. PWA was performed after 1 
hour of supine rest. Radial arterial tonometry was performed using the SphygmoCor 
Px system (AtCor Medical, NSW, Australia) with a Miller tonometer (Miller 
instruments, TX, USA). Tonometry was performed continuously for 30 seconds in a 
resting state and an average waveform was generated. The analysis was performed a 
total of 4 times, two successful readings followed by 5 minutes rest followed by two 
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additional readings. Relevant measurements were derived from each waveform and 
the results from the 4 repetitions were averaged to give values for statistical analysis. 
 
5.2 Meta-analysis results for ORCADES and KORČULA  
5.2.1 Phenotypic Distributions 
The two populations showed differences in the distributions of the majority of PWA 
phenotypes assessed (Table 15). Overall the differences correspond to a longer, 
slower pulse wave and lower pressure in the ORCADES population suggesting a 
lower degree of arterial stiffness in this population compared to the KORČULA 
population. This is not unexpected given that the ORCADES samples used in this 
analysis were on average 2.6 years younger than the KORČULA samples while also 
having lower average weight (-1.3 kg) and BMI (-0.2 kg/m2). The ORCADES 
samples also had slower average heart rates (-3.4 bpm) and, as previously discussed 
the rates of diabetes and hyperglycaemia, both of which are known risk factors for 
CVD, in the study are also considerably higher than in the ORCADES population. 
 
Differences of these kinds are not unexpected given the large distance, both 
geographically and perhaps culturally, between the two populations. Perhaps the 
most surprising thing is the direction of these differences. The traditional 
mediterannean diet has been cited numerous times as highly beneficial in preventing 
and controlling cardio-metabolic diseases (Esposito, Ciotola et al. 2007; Urquiaga, 
Echeverria et al. 2008; Babio, Bullo et al. 2009; Champagne 2009; Perez-Lopez, 
Chedraui et al. 2009; Proietti, del Balzo et al. 2009) while Scotland in general has 
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been suggested in the past to have an extremely poor diet in relation to CVD risk 
(Woodward and Tunstall-Pedoe 1995). The observed differences may suggest the 
lifestyle of Orcadians is healthier and unrepresentative of mainland Scottish 
populations or the difference in age and gender breakdown between the ORCADES 
and KORČULA studies may confound the expected health relationships. 
 
Since the PWA traits we studied are derived from a single waveform there is a high 
degree of phenotypic correlation particularly between the measures of systolic 
pressure and augmentation. Age and sex adjusted correlation coefficients calculated 
using the ORCADES data for key traits are shown in table 14. 
 
















P-MaxDp/dt 1.00 0.24 0.73 0.13 -0.05 0.78 -0.21 
P-ΔT (ms) 0.24 1.00 -0.06 -0.21 -0.23 0.03 0.19 
P-SP (mmHg) 0.73 -0.06 1.00 0.67 0.18 0.80 -0.24 
P-DP (mmHg) 0.13 -0.21 0.67 1.00 0.32 0.19 -0.15 
C-AIx -0.05 -0.23 0.18 0.32 1.00 0.33 0.22 
C-PP (mmHg) 0.78 0.03 0.80 0.19 0.33 1.00 -0.07 
C-SVI -0.21 0.19 -0.24 -0.15 0.22 -0.07 1.00 
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Normal distributions were observed for the following phenotypes: AIx, the time of 
the reflected wave and the interval between systolic and reflected waves. All other 
phenotypes deviated from the normal distribution as assessed by the Shapiro-Wilks 
test. To allow for the accurate calculation of, and correction for, polygenic variance 
we used rank transformation to achieve normal distributions for all phenotypes. 
 
5.2.2 Heritability estimates 
Heritability estimates for many of the traits were different between the two study 
populations, with estimates from the ORCADES population generally being higher 
than those from the KORČULA population. However, standard errors in the 
KORČULA population estimates were high and many of the heritability estimates 
for this study are not statistically significant. There are several possible explanations 
for the differences shown. Firstly, accurate heritability estimates can only be 
obtained with a sufficient number of closely related individuals. For the purposes of 
PWA the sample size of the ORCADES study was approximately 19.7% larger than 
the KORČULA project. The level of kinship within the KORČULA study was lower, 
with average pairwise estimates of 0.0029 compared with the ORCADES estimate of 
0.0046 indicating the presence of less family structure. Looking specifically at 
pairwise kinships above 0.35 that would suggest a full-sib or parent-offspring pairing 
we find 262 pairs in the KORČULA study and 547 in ORCADES, demonstrating a 
substantially higher level of close family structure. This suggests the ORCADES 
study would be expected to give considerably more reliable heritability estimates. 
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In addition to the size and genetic structure of the two studies we may also expect a 
greater deal of experimental variation in the KORČULA study because, while the 
ORCADES PWA measurements were all collected by, or under the observation of, a 
single individual who had many years of experience working with the equipment, the 
measures for KORČULA were collected by a number of field workers some of 
whom had only recently been trained in PWA.  
 
Lastly, as with all the phenotypes measured in these studies, there may truly be 
greater levels of environmental variance in one population or the other resulting in a 
proportional reduction in genetic heritability. 
 
Table 15. PWA trait descriptions and heritability estimates by population 
 KORČULA ORCADES 
  Mean s.d. h2 S.E. p-value Mean s.d. h2 S.E p-value 
N 487         583         
% Female 64         53.5         
Age (yrs) 56.2 13.9       53.6 15.7       
weight (kg) 79.2 14.4       77.9 15.3       
height (m) 1.68 0.09       1.67 0.09       
bmi (kg/m2) 28 4.15       27.8 4.86       
HR (bpm) 63.3 9.29 0.18 0.24 0.45 59.9 8.74 0.32 0.1 1.8x10-3 
P-MaxDp/dt 862 320 0.33 0.13 0.01 809 228 0.22 0.1 0.02 
P-T1 (ms) 110 14.6 0.54 0.16 7.6x10-4 112 17 0.04 0.05 0.42 
P-T2 (ms) 222 21.4 0.12 0.1 0.24 234 19.9 0.24 0.08 4.4x10-3 
P-ΔT (ms) 113 22.9 0.35 0.13 0.01 122 22.2 0.36 0.08 2.1x10-5 
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P-AIx 82.5 17.5 0.07 0.07 0.33 75.3 19.2 0.19 0.06 3.3x10-3 
P-SP (mmHg) 138 21.8 0.33 0.15 0.03 130 17.9 0.21 0.08 0.01 
P-DP (mmHg) 82.1 9.64 0.13 0.12 0.28 75.5 9.17 0.25 0.09 3.5x10-3 
P-EDA (ms) 335 21.7 0.26 0.15 0.09 338 21.9 0.6 0.11 1.4x10-8 
P-ESP (mmHg) 104 14 0.04 0.06 0.5 96 13.8 0.27 0.08 1.3x10-3 
P-MeanP 102 13.4 0.09 0.1 0.37 93.8 12.3 0.25 0.09 3.5x10-3 
                      
C-T1 (ms) 106 10.3 0.24 0.14 0.1 111 11.7 0.28 0.09 1.5x10-3 
C-T2 (ms) 234 18.4 0.34 0.23 0.13 235 20.5 0.21 0.08 0.01 
C-ΔT (ms) 127 20.9 0.22 0.14 0.11 124 24.1 0.19 0.07 0.01 
C-AIx 27.6 11.8 0.05 0.06 0.38 22.9 14.4 0.18 0.05 9.3x10-4 
C-AIx75 22 11.3 0 0 0.5 15.6 14.4 0.22 0.08 3.5x10-3 
C-AP (mmHg) 13.5 8.37 0.09 0.09 0.29 10.9 8.68 0.28 0.08 4.8x10-4 
C-ESP (mmHg) 114 17.2 0.15 0.15 0.31 106 16.5 0.26 0.08 1.3x10-3 
C-SP (mmHg) 128 21.5 0.25 0.15 0.11 118 19.1 0.24 0.08 3.5x10-3 
C-PP (mmHg) 45.1 16.2 0.16 0.08 0.04 42 13.8 0.36 0.11 1.3x10-3 
C-SVI 155 27.7 0.11 0.08 0.18 166 31.3 0.09 0.05 0.05 
 
5.3 Association Analysis 
 Due to the relatively small number of samples from each population we focused 
only on the results of the meta-analysis of both studies giving a combined initial 
sample of up to 1060 individuals. This can also provide a form of internal replication 
as results showing a consistent direction and magnitude of effect in both study 
populations will have increased significance while false positives, arising from 
purely random correlation of genotype and phenotype in one study, are statistically 
unlikely to also be associated in the other study. 




Meta-analysis of the two populations was performed for all subjects and separately 
for sex-specific sub groups. As with the glycaemic phenotypes, analysis was 
performed initially on rank-transformed phenotypes as the polygenic estimation 
method used to obtain residual phenotypic variance assumes a normally distributed 
phenotype. Subsequently the tests for significantly associated SNPs were repeated on 
untransformed variables to obtain effect estimates on a clinically meaningful scale.  
 
Looking initially at the relatively simple and commonly used measures of HR and P-
DP we can see from the QQ plots (figures 28 and 29) that the test statistics did not 
deviate greatly from the expected distribution under the null hypothesis. In contrast 
the P-DP analysis shows an inflation of the test statistics at the 1x10-5 level. From the 
genome-wide association plot (figure 30) we can see that the four most highly 
significant results for P-DP fall within the same region of chromosome 9. The 
strongest associated marker, rs574090 (p=2.3 x 10-7), is situated in an intron of the 
gene ADAMTSL1. 
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Figure 28. QQ plot of heart rate GWAS meta-analysis results in ORCADES and KORCULA 
studies 
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Figure 29. QQ plot of peripheral diastolic pressure GWAS meta-analysis results in ORCADES 
and KORCULA studies 
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Figure 30. GWAS meta-analysis results for peripheral diastolic pressure 
 
The QQ plots for C-AIx and the heart rate adjusted C-AIx75 both show a certain 
degree of inflation at the higher test statistics with the effect being more pronounced 
in the C-AIx75 results. This may indicate that, as we hoped, removing the “noisy” 
variance in augmentation caused by variable heart rate allows for better detection of 
genetic sources of variance. 
 
The two association scans show a potential region of interest on chromosome 16. 
The strongest association is with SNP rs4843294 while several other markers in the 
region show weaker levels of association. This result is stronger in the heart rate 
corrected C-AIx75 analysis with the p-value moving from 7.0x10-7 in C-AIx to 
2.2x10-7 in C-AIx75. The peak is located within an intron of the BANP gene. 
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Figure 31. QQ plot of central augmentation index GWAS meta-analysis results 
 
Figure 32. QQ plot of heart rate corrected central augmentation index GWAS meta-analysis 
results 
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Figure 33. GWAS meta-analysis results for central augmentation index 
 
Figure 34. GWAS meta-analysis results for heart rate corrected central augmentation index 
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The wave interval measure C-ΔT gave a near genome-wide significant result on 
chromosome 21 (rs9981633, P=2.4x10-7). 
 
Figure 35. GWAS meta-analysis results for time interval between outgoing and reflected 
pressure waves 
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Figure 36. QQ plot of heart rate corrected central augmentation index GWAS meta-analysis 
results 
 
Several of the most promising markers, chosen based on strength of association and 
genomic context, were genotyped in an independent sample of ~3000 healthy 
individuals from the Anglo-Cardiff Collaborative Trial (ACCT) who had been 
previously measured for some of the PWA phenotypes. The results (table 16) show 
replication at a nominal P-value of 0.01 for the rs574090 association with P-DP but 
unfortunately fail to provide replication for any of the derived central pulse wave 
phenotypes.  
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Table 16. Discovery meta-analysis and ACCT replication results for selected PWA SNPs 









rs4843294 C-AIx 1069 0.74 -2.29 0.44 2.2x10-07 -0.5 0.47 0.28 
rs574090 P-DP 1075 0.88 -3.18 0.62 2.3x10-07 1.87 0.72 0.01 
rs4793570 C-ESP 1075 0.27 -3.05 0.67 5.5x10-06 -0.63 0.86 0.46 
rs9304718 C-SP 1075 0.36 2.95 0.74 6.4x10-05 0.67 0.88 0.45 
 
With only four markers and a prior expectation of association there is no way to 
identify or correct for inflation of the test statistics in the ACCT study. However 
since these samples were randomly selected from across England and Wales and 
consist of unrelated individuals we would not expect significant inflation to be 
present and, in the absence of any strongly replicating marker we can safely assume 
that inflation is not an issue with these results. 
 
5.4 Conclusion 
The initial results from the two-population GWAS meta-analysis provided several 
potential novel associations. However, as the results did not reach genome-wide 
significance in the initial analysis and given the lack of replication for these results in 
the considerably larger ACCT study we may conclude that the results are most likely 
false positive associations.   




The positive inflation in test statistics demonstrated by the QQ-plots for several of 
the traits may indicate there are genuine genetic factors that could be identified from 
these populations but a large scale replication effort including several hundred of the 
top markers may be necessary to distinguish between the true and false positives. 
 
Increasing the initial GWAS sample size would also have major benefits in 
increasing the power to detect real associations at a given significance threshold. In 
this respect planned expansion of the ORCADES study and addition of other cohorts 
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6 Chapter 6: Discussion 
This project had two intrinsically linked aims. One was to attempt to identify novel 
quantitative trait loci that were involved in the control of metabolic and 
cardiovascular phenotypes and which may therefore be related to the common 
complex diseases of T2D and CVD. The second was to explore the specialized 
methodologies required to identify such QTLs using isolated population studies. 
 
6.1 Linkage 
In respect of the second aim I initially attempted linkage analysis of FG levels, as 
this was by far the mostly widely available phenotype in our study populations. The 
results of this analysis were not particularly strong, with no peak reaching the 
significance level for our meta-analysis and only one peak, on chromosome 17 in 
ERF, reaching the individual population significance threshold. Two of the sub-
significant peaks I detected did overlap with previously reported linkage results for 
glucose or T2D studies suggesting they may be more likely to be genuine linkage 
signals. 
 
These possible linkage signals on their own do not yield a great deal of information 
about possible FG related genes. The vast width of the peaks I detected contain 
hundred of possible genes, any of which could theoretically be the source of the 
linkage signal.  
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To attempt to narrow down the field of targets and to provide some degree of 
confirmation of the linkage signals, single point association analysis was done using 
the SNP data available for each cohort. These association results did not provide any 
additional support for the majority of the linkage peaks. The peak on chromosome 17 
did show some degree of association. In both the linkage and association analysis 
this result was only seen in the ERF population. This could indicate the presence of a 
population specific polymorphism with a strong effect on FG levels but with no 
visible effect in the other EUROSPAN populations this is a difficult hypothesis to 
pursue. 
 
The linkage analysis had several limitations, each of which probably contributed to 
the lack of substantial results. Firstly the studies used were not designed specifically 
to recruit families and so the level and nature of pedigree structure varies from one 
study to the next. This makes it difficult to estimate the power for linkage analysis 
within these populations. However, given the inconsistent results obtained between 
the four study populations and the weak overall results obtained from meta-analysis 
it may be safe to conclude that they were not sufficiently powered for analysis of a 
phenotype as highly polygenic as FG.  
 
The second problematic element of the linkage analysis was the fact that each of the 
studies had been genotyped using a different set of genetic markers and in fact the 
ERF study had used an entirely different class of markers to the other EUROSPAN 
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studies. Additionally, the NSPHS microsatellite marker positions were reported on a 
different genetic map to the other datasets. 
 
While I and the other EUROSPAN analysts attempted to overcome these differences 
by interpolating the NSPHS map positions and calculating MIBD estimates at 
arbitrary intervals along chromosomes rather than at individual marker positions, the 
resulting meta-analysis alignments may not be as accurate as would have been 
possible if a consensus marker panel had been typed in all populations. 
 
Besides any drawbacks with the study design, the linkage method is inherently 
limited to detecting rare variants with large individual effects. Given what we now 
know about the genetics of FG, with 16 replicated variants each of which exerts only 
a small influence on FG levels (Dupuis, Langenberg et al. 2010), the linkage method 
may not be an appropriate choice for studies of this type of highly polygenic 
phenotype. 
 
6.2 Association methods 
While the family structure of our isolated populations had potential benefits for 
linkage mapping, it was simultaneously troublesome for the purposes of basic 
association analysis. It became clear early on in the project that the widely used GC 
correction method would not be appropriate or sufficient to correct for the high 
levels of inflation seen in our GWAS statistics. 
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The use of pedigree-based kinship correction to obtain residual phenotypes under the 
GRAMMAR model overcame the family-based inflation in a reasonably accurate 
fashion. It did however introduce its own problems in that it required complete 
pedigree information, which in human populations is all but impossible to obtain. My 
implementation of the GRAMMAR method also required the polygenic correction 
and association analysis steps to be performed in separate programs using separate 
data formats, thus increasing the chances of user-generated errors. 
 
The GRAMMAR method may have been acceptable for use in the EUROSPAN 
populations, all of which had extensive pedigree information. However with the 
addition of the KORČULA study, which was prediced to have a substantial degree of 
family stucture but for which no deep pedigree information was avaiable, an 
alternative method would have been required. 
 
The third possible correction method I investigated was the use of genomic based 
kinship estimates as implemented in the GenABEL analysis package. The use of 
genomic rather than pedigree-based kinship overcame many of the problems and 
pitfalls of the GRAMMAR protocol. Most importantly for the KORČULA analysis 
was the fact that no pedigree information was required and the method can be used in 
any population for which significant population structure is predicted. 
 
More widely the method is beneficial even where some pedigree information has 
been collected since it does not really on the accuracy or completeness of this data. I 
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would also suggest that, even in the hypothetical scenario of having a complete and 
accurate pedigree, the genomic kinship estimate is more useful for the correction of 
polygenic trait variance because it accounts for the stochastic variance brought on by 
semi-random meotic events. 
 
Lastly I would argue the benefits of conducting both the polygenic phenotype 
correction and association analysis within a single program. This was not only faster 
and more convenient for the analyst but also reduced the chances of simple but 
difficult to identify mistakes being made as the data were reformatted and 
transferred.  
 
6.3 Glycaemic association results 
In the respect of identifying novel QTLs, the most significant success from the 
project was the identification of the association between the TCF7L2 locus and 
HbA1C variation in healthy individuals. While this locus has been previously and 
repeatedly shown to be associated with T2D it had not been previously demonstrated 
to influence HbA1C or, until very recently(Dupuis, Langenberg et al. 2010), FG 
levels in non-diabetic individuals. This result may therefore contribute additional 
information about the mechanism by which TCF7L2 polymorphisms act to increase 
T2D risk. 
 
The TCF7L2 locus has not been identified as a significant factor in other GWAS 
studies of HbA1C and a recently published large-scale meta-analysis of the trait also 
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failed to show a strong effect for this locus (Soranzo, Sanna et al. 2010). This 
repeated failure to replicate would usually strongly suggest that the result observed in 
my analysis is a false positive. However there is a strong biological relationship 
between HbA1C and T2D and given that TCF7L2 is an extremely well replicated 
T2D locus the question of whether my result is genuine requires closer examination. 
 
Arguing from the position that the result is false, the first argument one could make 
is that the association, like many other non-replicated results, is a statistical artefact 
arising by pure chance. Using a Bonferroni correction of the P-value of 1.48x10-7 
for 256,587 SNPs included in the HbA1C meta-analysis the empirical P-value is just 
0.038. If I also took into account the various other GWAS scans I perform on various 
phenotypes then some would argue we should expect to find one or more results at 
this level. 
 
In response I would argue that the probability that the marker showing the most 
significant result in an analysis of 256,587 SNPs would also happen to be widely 
reported in analysis of a strongly related disease is extremely small.  
 
The relationship between the HbA1C phenotype and T2D status leads to a second 
possible argument against the validity of the result. The HbA1C measurements of 
T2D patients are generally considerably higher than those of healthy individuals. We 
would therefore expect to find, in a population containing significant numbers of 
T2D sufferers, some degree of association between HbA1C and any sufficiently 
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strong T2D locus. Despite my efforts to exclude people with diabetes from analysis 
this phenomenon could still be an issue.  
 
Due to the variable types of data available for the various cohorts used in my meta-
analyses, the two exclusion criteria used were self-reported anti-diabetic medications 
and hyperglycaemia based on FG levels. This means that hypothetically; a diet 
controlled T2D patient who had successfully reduced their FG levels below 7mmol/L 
would be retained in our analysis.  I do not believe this to be the foundation of the 
TCF7L2 association, as I would only expect a very small proportion of individuals to 
fall into this category. 
 
There are also several explanations as to why the association may not be observed in 
other published studies despite being a genuine result. Firstly, one of the original 
rationales for using isolated populations was the relative reduction in genetic 
heterogeneity and environmental variance compared with urban populations. Both of 
these factors generate phenotypic “noise” and may potentially mask the relatively 
small effect of an individual QTL.  
 
Secondly we must consider the power of the studies. It is not unusual or unexpected 
for relatively small studies, each of which samples a few thousand individuals, to 
give conflicting results. The seemingly large phenotypic effect of the TCF7L2 
variant in my analysis may suggest that relatively small sample sizes would be 
required to replicate the finding. However, effect estimates from studies that first 
Linkage and Association Mapping for Quantitative Phenotypes in Isolated Populations 
 
 138 
identify a new locus are generally higher than estimates from subsequent replication 
studies, a phenomenon known as the winners curse (Kraft 2008). This means the true 
effect of this variant on HbA1C levels is likely to be considerably smaller than it 
appears in my analysis, and so this locus could easily be missed in other relatively 
small studies. 
 
The largest published GWAS study of HbA1C by the MAGIC consortium totaled 
almost 36 thousand individuals and was estimated to have 80% power to detect 
variants responsible for as little as 0.12% of total phenotypic variance (Soranzo, 
Sanna et al. 2010). While this type of large collaboration may give increased power it 
also creates certain issues. 
 
When combining the analysis of many studies conducted by different research 
groups there are a variety of sources of heterogeneity and potential error. As 
observed in the relatively small EUROSPAN meta-analysis there may be different 
sources of environmental variance on any given phenotype in different populations. 
Secondly the experimental protocols used to measure phenotypes and collect relevant 
covariates may be different, and have differing levels of accuracy, between studies. 
There is also an issue when conducting a large meta-analysis of unified analysis 
protocols. Depending on the structure of the collaboration the analysis of each 
individual study may be conducted by a separate individual and, while all analysts 
may be following the same protocol, this means a mistake by any one of dozens of 
individuals could adversely affect results. These factors can all lead to increased 
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levels of environmental or error variance and may mask the effects of underlying 
genetic loci. 
 
There is also a potential issue of genetic heterogeneity. Some genetic variants may be 
far less frequent or even absent in certain populations due to historical population 
bottlenecks or genetic drift. The addition of these study populations to a meta-
analysis would therefore dilute the evidence for that particular variant. 
 
The LD structure can also vary from one population to another and this can have 
major implications for the association analysis method. Since we do not necessarily 
expect the SNP variants we are testing in GWAS to be the actual causal variant we 
rely on the degree and direction of genotypic correlation between our SNP and the 
unobserved locus being the same in our separate study populations. If this LD 
relationship had been broken down in a particular study then the association with our 
SNP would no longer be present and, in a more extreme scenario, if the LD 
relationship had been reversed in a particular population, which may occur during a 
population bottleneck, that evidence from that study population would be 
contradictory and reduce the overall meta-analysis statistic by a substantial amount. 
 
In addition to the identification of a new HbA1C association my meta-analysis of FG 
levels also showed replication to varying degrees of 9 out of 16 published loci, which 
were tagged by SNPs on our marker panel. Though it must be noted that analysis of 
the EUROSPAN populations was also included in one of the major FG meta-analysis 
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(Dupuis, Langenberg et al. 2010). Additionally 1 of 2 well-replicated FI loci, the 
insulin like growth factor 1 (IGF1), showed nominal association in our data 
(p=0.006). 
 
At the same time it is interesting that a further 7 FG and the remaining 1 FI loci 
showed no evidence for association in our study populations. As already mentioned 
the power for our study to identify small effect loci at genome-wide significance 
levels is quite low and the limited number of studies for which FI was measured 
decreases the power further in that analysis. However, even for a locus whose effect 
accounted for 0.5% of total phenotypic variance, we would expect to have more than 
80% power to detect the variant at a p-value of 0.001 (Purcell, Cherny et al. 2003), 
using our 4,000 sample FG meta-analysis. This suggests that some of the loci 
identified by large-scale multinational meta-analyses may not be having an effect in 
our population isolates. There are many plausible explanations for how this could 
occur.  
 
While we expect the overall LD in our isolated populations to be stronger than that 
found in larger populations, it is also plausible that different patterns of LD could 
have developed in some of our study populations. This may mean that markers that 
are in LD with a causative variant in European populations at large do not show the 
same correlation in our studies. The possibility of discrepancies between LD 
structure in our studies and that found in the CEU HapMap samples is difficult to 
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assess, as we do not have substantial numbers of founder individuals with which to 
calculate LD. 
 
Another possible explanation for our inability to replicate some of the major FG loci 
is that population bottlenecks and low effective population sizes increase the chance 
of random genetic drift changing allele frequencies or even taking them to fixation in 
the population. While this would be easily observable at directly genotyped variants, 
it could result in unobserved causative variants being present at very different 
frequencies, or not present at all, in our study populations. 
 
A further consideration is the possibility of currently unknown genetic or 
environmental modifiers that are necessary for a given locus to influence a trait. In 
the case of environmental factors this could be a result of the dietary intake of some 
of our study populations being generally healthier. Many loci have been identified 
recently with significant effects on obesity (Fawcett and Barroso 2010) but arguably 
they only show such strong influences in populations with access to large quantities 
of sugar and fat rich food. In the example of genetic modifiers the influence of a 
locus on a given phenotype may be dependent on the presence or absence of a 
second variant. The disentanglement of this type of interaction relationship is 
extremely difficult as, theoretically, any two loci in the genome could be interacting. 
Testing all possible combinations of SNPs instantly turns the millions of tests that 
are common in GWAS studies into trillions of tests, and the type I error rate 
increases accordingly. 




The effect size estimates for loci that have been consistently associated with FG for 
example range between 0.012 (IGF1) and 0.075 (G6PC2) mmol/l per allele, and 
even collectively the 16 strongest known FG loci are only estimated to account for 
approximately 3-4% of total phenotypic variance (Dupuis, Langenberg et al. 2010).  
 
So we can see that an individual study such as the ORCADES project with 
approximately 700 genotyped and phenotyped samples will have very limited power 
to identify even the strongest of these loci. 
 
Expanding to a relatively small collaboration like EUROSPAN, which with the 
addition of the KORČULA project gave a total sample size of approximately 4000 
samples for FG analysis, greatly increases our power to detect loci with effects 
similar to the known FG loci but simultaneously introduces problems of inter study 
genetic and phenotypic heterogeneity.  
 
To further address the issue of power and extract as much value as possible from the 
EUROSPAN data sets we contributed analysis of FG, HbA1C, Insulin and the 
HOMA-B HOMA-IR phenotypes to the meta-analysis of glucose and insulin related 
traits consortium (MAGIC) (Dupuis, Langenberg et al. 2010). Having collected 
together 21 GWAS studies and a large number of suitable replication samples the 
MAGIC consortium were about to reach sample sizes of between 98,372 and 
Linkage and Association Mapping for Quantitative Phenotypes in Isolated Populations 
 
 143 
122,743 for the various glycaemic phenotypes. It is at these levels that power exists 
to reliably identify loci with very small effect sizes. 
 
Despite only having small numbers of type 2 diabetes cases roughly proportional to 
the population prevalence we were also able to contribute case control analysis 
results to a large scale meta-analysis (Voight, Scott et al. 2010). The small number of 
cases within our own studies made independent case control analysis largely 
redundant and, as previously discussed, methods to correct for the effects of diabetes 
medication on the glycaemic phenotypes were not applicable when such small 
numbers were available to calculate the medication effect estimates. This means that 
joining the large-scale meta-analysis made use of genotyped individuals who would 
not otherwise have been contributed to diabetes and related traits research. 
 
6.4 Pulse wave analysis 
Use of the PWA phenotypes had potential benefits in that this measurement is so 
difficult and time-consuming to obtain that very few genetic studies have used it to 
date. Unfortunately this also meant that only two of the study populations had data 
for PWA and the numbers of measured individuals within these studies were lower 
than for the more common biochemical and anthropometric phenotypes. 
 
The estimation of PWA heritability in the ORCADES and KORČULA studies 
showed very inconsistent results. The KORČULA estimates were generally not 
statistically significant due to high standard errors. This could either be the result of 
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increased measurement error in therefore proportionally decreased genetic variance, 
or it could relate to the lower levels of kinship present in the KORČULA population 
and a reduced ability to estimate heritability. 
 
In terms of association results the PWA did not reveal any convincing candidate loci. 
The strongest result from across the analysis was the association between marker 
rs574090 and peripheral diastolic pressure. This SNP also showed a nominal 
significance in the ACCT replication samples, the effect here however was in the 
opposite direction to the ORCADES and KORČULA populations. 
 
The issues of power as discussed in relation to the glycaemic phenotypes are even 
more relevent to the lack of PWA association hits. With a sample size of little over 
1,000 individuals across the two meta-analysis populations we would only have 80% 
power to detect very strong variants accounting for more than 4% of total phenotypic 
variance. Given the difficulties of obtaining accurate and consistent blood pressure 
measurements as previously discussed it is highly unlikely that a common genetic 
variant would account for that proportion of variance. 
 
6.5 Extensions and alternatives to genome-wide association 
analysis 
The simplest strategy for increasing power and improving results from GWAS 
studies is to increase the number of samples. This can be achieved, as in the 
Linkage and Association Mapping for Quantitative Phenotypes in Isolated Populations 
 
 145 
EUROSPAN, MAGIC and other collaborations, by combining analysis from many 
individual studies, though this type of meta-analysis comes with many hurdles and 
limitations as previously discussed. It would clearly be preferable to collect very 
large samples within a single study framework, which would allow for true 
standardization of data collection and analysis methods. The potential for this is 
obviously limited by the size of available research grants, but as the cost of 
genotyping technology has and continues to lower the feasibility of collecting and 
genotyping tens of thousands of samples within a single study increases. 
 
In the absence of a very large samples size, one alternative economical method for 
improving study power is to implement a two-stage study design. The first stage is to 
type a genome-wide SNP panel on a subset of samples and conduct a standard 
GWAS analysis. The second stage is then essentially a large-scale replication using 
the remaining samples. Rather than choosing only a small set of SNPs with genome-
wide significant P-values one can, with sufficient funds, take forward several 
thousand markers to the second stage chosen either using an arbitrary significance 
threshold or by taking a certain proportion of the most significant SNPs. 
 
This two-step study design differs from more common replication efforts in that the 
SNPs used for replication, or at least the majority of them, are not expected to 
successfully replicate. Assuming the first stage study were to use the same genotype 
chip used in the EUROSPAN analysis with roughly 300,000 SNPs and an arbitrary 
P-value cut off of 0.001 one would expect to find approximately 300 SNPs that have 
Linkage and Association Mapping for Quantitative Phenotypes in Isolated Populations 
 
 146 
no genuine role in the phenotype being studied. Analyses that find a large excess of 
results at this level but which do not identify genome-wide significant results may 
indicated that a large number of weak effects are present. One potential replication 
strategy would therefore be to identify a significance threshold in your first stage 
study at which an excess of associations are found and then attempt replication of all 
markers above this threshold. 
 
The ability to identify true QTL signals is also dependent on having sufficient 
coverage of the genome and the Illumina 317k chip used in the EUROSPAN 
population has been estimated to have as little as 59% coverage in European 
populations (Wollstein, Herrmann et al. 2007). While the density of SNP arrays has 
increased during the course of this project and chips with over 1 million SNPs are 
now available, complete coverage based on LD is almost impossible to achieve due 
to mutation hotspots (Tian, Wang et al. 2008) and variable recombination rates 
across the genome (Gay, Myers et al. 2007). The only sure-fire way of identifying all 
genetic variants an individual is carrying is through sequencing, a process that is still 
relatively time consuming and expensive when compared to micro-array based 
genotyping.  
 
While whole genome sequencing may not yet be feasible for most research groups, 
collaborative projects are underway to sequence and make available the genomes of 
thousands of individuals (www.1000genomes.org). The availability of these 
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sequence data will enable groups with sufficient genotype data to impute the vast 
majority of common genetic variants present in their population.  
 
Application of this whole sequence imputation to isolated populations such as 
ORCADES would have the same caveats as previous imputation methods in that 
differences in LD structure and genetic drift would result in lower accuracy. 
However, isolated populations also have a potential advantage in this respect. Thanks 
to the extensive family structure present in ORCADES and similar studies a 
relatively small number of sequenced samples could be used to accurately impute 
and phase the whole genome sequence of hundreds of genotyped samples. This 
pedigree based sequence imputation means that not only should it be possible to 
identify the actual causal variant for a given phenotype or disease, but also to trace 
parent of origin for each allele. 
 
There is another likely outcome of the decreasing cost and increasing availability of 
sequencing technologies in the reversal of some traditional selection strategies. One 
of the proposed benefits of the isolated population study design was the ability to 
collect a large number of phenotypes all of which could be tested using a single set 
of genotypes. This strategy is indeed highly efficient when the cost of genotyping is 
very high and the cost of phenotyping is reasonably low.  With a similar purpose, 
some studies have previously used selective genotyping strategies whereby a large 
number of individuals are phenotyped for a quantitative trait, but only the tail ends of 
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the distribution are sent on for genotyping in an attempt to maximize the genetic 
differences between them. 
 
As high density genotyping and sequencing become ever cheaper, and geneticists 
attempt to tackle ever more complex and intensive phenotypes such as PWA, the 
economy of these types of strategies decreases. A situation is feasible whereby 
instead of phenotyping a large number of individuals and choosing a subset for 
genotyping, one could genotype a very large number of unselected individuals and 
choose a subset from this pool to send forward for intensive phenotyping. This 
strategy would obviously require a return to candidate gene selection in order to 
choose the phenotyping pool, but in light of several years of successful GWAS 
studies the knowledge on which to choose one’s candidates is greatly increased. 
 
The strategy would particularly benefit the study of rare variants. Given a very large 
sample of say 100,000 genotyped individuals, a variant with a minor allele frequency 
of 1% would be predicted to occur in approximately 1,000 of those samples. 
Assuming this low frequency variant was of interest one could preferentially 
approach those 1,000 individuals plus 1,000 individuals chosen randomly from the 
remaining pool for phenotyping, one could then test for the hypothesized effect of 
the rare variant with substantial power. 
 
In addition to new methods to identify risk loci it is important to translate findings 
into clinically meaningful resources. With respect to the findings presented in this 
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thesis; the TCF7L2 locus was first shown as a risk locus for T2D(Grant, Thorleifsson 
et al. 2006), it has since been shown to influence insulin secretion(da Silva Xavier, 
Loder et al. 2009) and from my own work to play a role in control of HbA1c levels 
in the non-diabetic population(Franklin, Aulchenko et al. 2010). The risk allele at 
this locus has been shown to not only increase lifetime risk of developing T2D but 
also is also associated with the age-of-onset for the disease(Lehman, Hunt et al. 
2007; Silbernagel, Renner et al. 2011). Perhaps the most clinically tractable finding 
to date with regard to the TCF7L2 locus is the reported and replicated finding that 
variation at this locus affects response to sulfonylureas a common form of treatment 
for T2D patients(Pearson, Donnelly et al. 2007; Holstein, Hahn et al. 2011). Findings 
of this type mean that the wealth of genetic information that has been gathered 
through genome-wide investigations of the last few years will increasingly find its 
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